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In this study, we report two previously unidentified mechanisms that governs β-lactam
and antimicrobial peptide resistance.
In Gram-negative bacteria, production of β-lactamases is often induced in response to
the antibiotic- associated damage to the cell wall. Here, we have identified a previously
unidentified mechanism that governs β-lactamase production. In the Gram-negative
enteric pathogen Vibrio parahaemolyticus, we found a histidine kinase/response
regulator pair (VbrK/VbrR) that controls expression of a β-lactamase. Mutants lacking
either VbrK or VbrR do not produce the β-lactamase and are no longer resistant to βlactam antibiotics. Notably, VbrK autophosphorylation is activated by β-lactam
antibiotics, but not by other lactams. However, single amino acid substitutions in the
putative periplasmic binding pocket of VbrK leads its phosphorylation in response to
both β-lactam and other lactams, suggesting that this kinase is a β-lactam receptor that
can directly detect β-lactam antibiotics instead of detecting the damage to cell wall
resulting from β-lactams. In strong support of this idea, we found that purified
periplasmic sensor domain of VbrK binds penicillin, and that such binding is critical for
VbrK autophosphorylation and β lactamase production. Direct recognition of β-lactam
antibiotics by a histidine kinase receptor may represent an evolutionarily favorable
mechanism to defend against β-lactam antibiotics.

Lu Li, University of Connecticut, 2018

Antimicrobial peptide is amphipathic peptide that inserts into phospholipid bilayer and
disrupt the integrity of bacterial cell membrane. Many bacteria employ the strategy of
LPS modification to resist attack from AMPs. Here, we have identified a mechanism that
governs LPS modification that has never been reported in Vibrio parahaemolyticus
before. We identified a histidine kinase/response regulator pair (PvrK/PvrR) that
controls expression a lipid A ethanolamine phosphotransferase (PEA transferase), an
enzyme adds positively charged phosphoethanolamine (PEA) to the core of lipid A.
Resistance to AMPs or the expression of PEA transferase drastically decrease in
mutants lacking either PvrK or PvrR. The autophosphorylation of PvrK can be
stimulated through either low Mg2+ concentration or the presence of AMPs, which
resembles the host environment when Vibrio parahaemolyticus invades the host.
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Chapter 1. Literature Review and General Introduction
1.1 Antibiotic resistant Vibrio parahaemolyticus
1.1.1 Vibrio parahaemolyticus as pathogenic bacteria
The discovery of antibiotics is a remarkable step forward in the history of human
medicine. As many antibiotics are derivatives of bacterial or fungus secretion, and also
because of widespread use of antibiotics in morden medicine, antibiotic resistance
among bacteria is becoming more and more prevalent. Understanding the differential
mechanisms by which bacteria become resistant as well as the systems bacteria apply
to regulate their antibiotic resistance has been the focus of study for many scientists.

Vibrio parahaemolyticus is gram negative bacterium that can be generally found in
blackish saltwater. When ingested, it can cause gastrointestinal illness in humans. In
most of the cases, ingestions of undercooked shellfish particularly oysters is considered
the route of transmission. However, in some cases, cooked seafood is responsible for
most of the outbreaks. It is believed that errors in refrigeration, cooking or foodhandling hygiene contributed to the incidents (1). The symptoms include watery
diarrhea, abdominal cramping, nausea, vomiting, fever and chills. If individuals get
infected with V. parahaemolyticus. Through wounded skin, abscesses with localized
cellulites may develop (2). The illnesses caused by V. parahaemolyticus in most cases
are self-limited. Complications may arise if the affected individual has a compromised
immune system or preexisting medical conditions such as liver diseases or diabetes (3).
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5% of the infections advanced to septicemia and nearly half of the cases become fatal
(4).
Strains of V. parahaemolyticus are typically serotyped based on somatic(O) antigens
and capsular (K) antigens. So far, 12 O groups and 71 K groups have been reported
(5). In 1996, a unique serotype O3:K6 emerged and quickly spread from India to
worldwide(6). In 1998, two V. parahaemolyticus outbreaks in New York state were
associated with O3:K6 strains (7), it then spread further to Chile and Europe, caused
thousands of infections and illnesses and resulted in several V. parahaemolyticus
pandemics (8, 9) .
The whole genome sequencing of clinical strain RIMD2210633 found confirmed that V.
parahaemolyticus contained two circular chromosomes of 3,288,558 bp and 1,877,212
bp and 4832 genes (10). Most of the genes required for growth and viability are on
chromosome 1, while more genes on chromosome 2 are related to transcriptional
regulation and virulence factors, including pathogenicity island (PAI), the thermostable
direct haemolysin gene(tdh), tdh-related haemolysin gene (trh) and type III secretion
systems (10).
TDH was considered one of the primary virulence factors of V. parahaemolyticus. It
forms a ~2nm pores on erythrocytes (11) and alters cl- and ca2+secretion of human
colonic epithelial cells that is responsible for the development of diarrhea (12, 13). TRH
is a heat labile protein and immunologically similar to TDH (14), it also activate clchannels and alters ion flux in small intestine (13). Although most of the clinical strains
contain either TDH or TRH, identification of clinical strains that contain neither toxins
indicate the existence of other important virulence factors that contribute to the
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pathogenicity of V. parahaemolyticus (15, 16) . This corresponds to one of the findings
where both TDH positive and negative strains of V. parahaemolyticus can disrupt
epithelial cell tight junctions (17). In another study, deletion of tdh genes completely
abolished the hemolytic activity but did not affect the cytotoxicity to HeLa cells. It was
also showed that tdh mutant can still cause fluid accumulation in the rabbit ileal loop
(18). All these results indicate that TDH and TRH alone are not fully responsible for the
cytotoxicity and enterotoxicity of pathogenic V. parahaemolyticus.
Type III of secretion system (T3SS) is another important virulence factor of V.
parahaemolyticus. It is a protein appendage found in many gram negative, pathogenic
bacteria. It is a needle like structure the composed of various structural proteins and
functional proteins. It functions as a sensory probe to detect the presence of its target
eukaryotic cells and is able to inject corresponding toxins into host cells. The strain
RIMD2210633 composes two type III of secretion systems: T3SS1 and T3SS2. T3SS1
is present in both pathogenic and non-pathogenic strains of V. parahaemolyticus, and is
responsible for cytotoxic activity(19), cell death and autophagy (20), and lethality in mice
(21); on the other hand, T3SS2 is only present in pathogenic strains (22) and is
associated with enterotoxicity (19, 21) and probably adaption of the bacteria to
environmental fitness (23). It is found that, several bile salts can activate transcriptional
factors vtrA and vtrB encoded in the PAI region of the bacteria, and further activate the
expression of T3SS2 components (24, 25). Important effector proteins of T3SS2 include
VopC, which mediates cdc42-dependent invasion of intestinal epithelial cells (26), VopL,
which promotes the assembly of actin filaments, VopV, which induces rearrangement of
the apical epithelial membrane through its interaction with actin or with actin cross-
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linking protein filaments (27) and VopZ, which inactivate both MAPK signaling pathway
by preventing the activation of TAK1 (28). All these effectors collectively are essential
for intestinal colonization, induction of diarrhea and general intestinal pathology.

1.1.2 Resistance of V. parahaemolyticus to antibiotics
1.1.2.1 General situation of antibiotic resistance worldwide
Dates back to 1928, the prototype of the first antibiotic penicillin: the “mold juice”, was
discovered by Alexander Fleming. In 1940’s, antibiotic application was introduced to the
public thanks to the World War II. Since then, more and more different antibiotics were
discovered modified, produced, and widely used through the world.
In the United States, it is reported that over 250 million antibiotic prescriptions are made
every year (29). In agriculture, antibiotics are used as veterinary medicine and feed
additives for livestock and poultry (30, 31). Antibiotics enter environment through
animal manure and human waste, and can persist in the environment for years (32, 33).
This has resulted in an unprecedented global increase in the incidences of bacteria
strains that are of multiple resistance to different antibiotics. Antibiotic resistance now is
becoming a more and more severe problem and has become a health crisis worldwide.
Each year in the United States, at least 2 million people become infected with bacteria
that are resistant to antibiotics and at least 23,000 people die each year as a direct
result of these infections (34). It is essential to understand where resistant pathogens
emerge, how drug resistance is conferred and transmitted among pathogens, and how
pathogens regulate those resistance genes.
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1.1.2.2 Mechanisms of antibiotic resistance
Development of antibiotic resistance in bacteria is inevitable and is natural result of
evolution. Since most of the antibiotics are derived secretions of fungus or bacteria
itself, antibiotic resistance was recorded even before the first clinical use of penicillin in
1940’s (35). There are five major antibiotic targets: bacterial cell wall, DNA synthesis,
RNA synthesis, protein synthesis and folic acid metabolism. Resistance to antibiotics
occurs through four basic mechanism: enzyme destruction, target modification, efflux
systems, and immunity and bypass. For enzyme destruction, many species of bacteria
have developed or acquired the ability to produce enzymes to digest various antibiotics.
The most classical example is b-lactamase, an enzyme that can directly break the fouratom ring of b-lactam antibiotics family, including penicillin, carbenicillin and
cephalosporins. For target modification, the bacteria modify the structure or composition
so that the antibiotics can longer bind to its original target. For example, methicillinresistant Staphylococcus aureus (MRSA) achieves high-level resistance to methicillin
and other b-lactam antibiotics through acquisition and expression of the mecA gene (36,
37). As the family of b-lactam antibiotics destruct bacteria cell wall by binding to
penicillin-binding protein (PBP), an enzyme that functions in cell wall peptidoglycan
synthesis, the mecA gene encodes an alternative penicillin-binding protein 2a (PBP2a)
that has a low affinity for beta-lactam antibiotics, hence prevents the cell wall synthesis
being inhibited by the antibiotics. The efflux system is one of the major causes of
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multidrug-resistance in bacteria. They can confer resistance not only to antibiotics but
also other substances produced by the host, such as bile, hormones and other hostdefense molecules. There are five major families of the efflux-pump proteins, including
ATP-binding cassette (ABC) superfamily, the major facilitator superfamily (MFS), the
multidrug and toxic-compound extrusion (MATE) family, the small multidrug resistance
(SMR) family and the resistance nodulation division (RND) family (38). One of the
model systems is AcrAB- TolC multidrug efflux pump in E.coli. It is composed a
transporter protein AcrB which is located in the inner membrane; a membrane-fusion
protein AcrA, which is located in the periplasmic space; and a channel protein TolC,
which is located in the outer membrane. The AcrB captures substrate (antibiotics) from
the cytoplasm or inner membrane and transport them through TolC to the extracellular
space. The cooperation between AcrB and TolC is through AcrA, whose dynamics is
drived by the proton motive force (39, 40). The best example of bacterial immunity to
antibiotics (and various other environmental stresses) is bacterial biofilm. The biofilm is
an organic matrix usually attached to a surface. It is a polymer of various different
components secreted by the bacteria population including polysaccharides, proteins,
and nucleic acid. The bacterial population is embedded within this matrix where they
develop into physiological status that is different to the planktonic form (41), thus endow
the population distinctive immunity to numerous environmental stresses, including its
inherent resistance to antimicrobial agents. One hypothesis says that the complex
matrix itself is a formidable penetration barrier to many antimicrobial agents, and this
theory has been proved by several experiments and mathematical models (42, 43). A
second theory is that some of the cells in the biofilm experience nutrition limitation and
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undergo into a starvation or dormant status, and starved cells in many cases are not
sensitive to many different antibiotics (44, 45).

1.1.2.3 Resistance of V. parahaemolyticus to b-lactam antibiotics
The b-lactams are the most widely used and among the most valuable classes of
antibiotics (46). These agents contain a β-lactam ring in their structures and inhibit the
activity of transpeptidases or penicillin binding proteins (PBPs), the essential enzymes
for the biosynthesis of peptidoglycan (PG) (47, 48), thereby damaging the integrity of
bacterial cell wall.

Although antibiotic resistance of V. parahaemolyticus is not the focus of research as
other enteric pathogens such as Vibrio cholera or Salmonella spp., all available studies
and surveys so far have reached to a consensus that β-lactam resistance in V.
parahaemolyticus is most prevalent and nonnegligible. A very high ampicillin resistance
rate was observed in pathogenic V. parahaemolyticus strains in the United States as
early as 1978, in an endemic of V. parahaemolyticus infection (49). In more recent
surveys carried out still in the US, of 168 V. parahaemolyticus isolates, more than 80%
were found resistant to ampicillin(MIC=32ug/ml) (50, 51). In one study carried out in
Europe, 107 V. parahaemolyticus strains were analyzed for antimicrobial susceptibility,
62% of all strains were resistant to four different classes of antibiotics and all isolates
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(100%) were resistant to ampicillin and amoxicillin. Of all the strains analyzed, 20
strains were clinical isolates (52). In a study carried out in Brazil, 90% of the V.
parahaemolyticus isolates derived from either fresh or frozen seafood were confirmed
resistant to ampicillin (53). Studies from Asia or other regions of the world also reported
similar results that resistance to β-lactam in V. parahaemolyticus is dominant. However,
the mechanism and regulatory of β-lactam resistance in V. parahaemolyticus remains
unclear.

In general, there are three primary mechanisms by which bacteria develop against
resistance toward β-lactam antibiotics. One of the principal mechanisms by which
bacteria develop resistance to β-lactam antibiotics is the production of intrinsic or
horizontally acquired β-lactamases that can degrade and inactivate β-lactams (54). In
many bacterial species, β-lactamase expression is inducible in response to β-lactam
antibiotic treatment. For example, in Gram positive bacteria, β-lactamase can be
induced directly by β-lactam antibiotics or indirectly by muropeptides that are released
from PG after β-lactam treatment (55). In Gram-negative bacteria (e.g.,
Enterobacteriaceae), muropeptide produced after β-lactam treatment can also induce
the expression β-lactamase (56, 57). In addition to β-lactam treatment, β-lactamase
expression in Gram-negative bacteria can also be induced by the changes of growth
rate (58, 59) The direct role of β-lactam in inducing the expression of β-lactamase in
Gram-negative bacteria has not been reported. Except for β-lactamase, another
mechanism of β-lactam resistance is, as mentioned above, through the alteration of the
antibiotic target site, which is a major cause of the resistance in gram positive
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pathogens including Staphylococcal and Streptococcal species. The final mechanism is
prevention of access of the antibiotic to the target by way of altered permeability or
forced efflux. For example, this can be performed by the MexA,B–OprM antibiotic efflux
pump, which is a major cause of resistance in Pseudomonas and in other pathogenic
Gram-negative species (60).

1.1.2.4 Resistance of V. parahaemolyticus to antimicrobial peptide
Antimicrobial peptides (AMPs) is part of the host innate immune response, study
showed that knockout mice with deficiencies in AMP production exhibited great
susceptibility to bacterial infection of skin and mucosal surfaces (61). Some
antimicrobial peptides have already been applied for clinical use, such as polymyxin B,
ambicin (nisin) and polymyxin E. Although there has been continuous debate over the
mechanism of action, all the theories are based on the cationic and sometimes
amphipathic nature of the substance. In either theory, the initial interaction between the
AMPs and target cell membrane is electrostatic, since the surface of cell envelop is
always anionic. When the concentration of peptides lying on the cell membrane reaches
to a threshold, the peptides insert themselves into the membrane and changes the
thickness or integrity of the membrane. Different insertion theories include peptide-lined
pores in the barrel-stave model, solubilize the membrane into micellar structure in the
carpet model, or form peptide-and-lipid-lined pores in the toroidal pore model (62). The
cell envelop can be totally destructed by the AMP, which directly leads to the lysis of the
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cell. Alternatively, the AMPs can get into cell and further affect other functions of the
cell, such as protein synthesis or proper functioning of the RNA polymerase.
As the microbes always find way to co-evolve with host’s immune system, the
pathogens employ several strategies to fight against AMPs. The most employed
strategy is through cell surface modification. In Gram negative bacteria, the outer leaflet
of the outer membrane is mainly composed of lipopolysaccharide (LPS), which include
three components: lipid A, core polysaccharide, and an O antigen. The lipid A is
essentially an anionic dimer of glucosamine linked to fatty acid chains and flanked by
polar phosphate groups. To prevent anionic phosphate groups repelling each other and
disturbing the stability of the outer membrane, divalent cationic ions such as Mg2+ or
Ca2+ are attracted to LPS. Displacement of the cations by AMPs makes bacteria
vulnerable to its attacks. Pathogens make various modifications to lipid A component to
make it more neutral electronically. For example, Salmonella enterica and
Pseudomonas aeruginosa developed AMP resistance by adding 4-aminoarabinose
(Ara4N) to the phosphate group of the lipid A backbone (63, 64). In another example for
S. enterica, the product of pagP increased acylation level of lipid A (65). The net effect
of all these substitutions is to render a more neutral LPS and repel positively-charged
AMPs before they can reach the cytoplasmic membrane. The second way of adaption
the allows certain bacteria to avoid being killed by AMP is to directly bind or neutralize
AMP. A secreted protein of Staphylococcus aureus known as staphylokinase can
directly bind alpha-defensins produced by neutrophils (66). Other resistance
mechanisms include efflux and proteolytic degradation of AMPs (67).
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So far, no documentation or study has reported on the susceptibility of V.
parahaemolyticus to AMPs. As antibiotics belonging to AMP family are considered the
last resort of antibiotic treatment, it is important to find out whether the bacteria employ
any strategy to make itself more resistant, and if any, how does the bacteria regulate
expression of resistance genes.

1.2 Two component regulatory system
Like all other life forms on the earth, microorganisms are facing environmental
fluctuations all the time. No matter whether the bacteria is in a planktonic form or is
infecting a host, availability of nutrients like carbons, oxygen, nitrogen, or environmental
conditions such as temperature, acidity, osmotic pressure and toxic substances etc. can
change quickly and drastically. The organisms have to constantly adjust to the dynamic
surroundings in order to survive, and such an adaption always rely on changing in
expression of a specific set of genes. One of such implements is known as two
component regulatory systems (TCSs)

A simplified model of TCS consist of a histidine kinase (HK) and a response regulator
(RR). In gram negative bacteria, HKs are inner membrane proteins which contains a Nterminal sensor domain in periplasmic region that monitor environmental stimuli, a
transmembrane domain that anchors the protein, and a C- terminal cytoplasmic domain
that binds to ATP and transfers signals. Upon detection of a specific signal, the sensor
domain changes its confirmation and results in autophosphorylation of conserved
histidine residue (His) in the cytoplasmic domain. The phosphoryl groups in most cases
11

are from the gamma-phosphoryl group in ATP. The cognate RR further catalyzes the
transfer of phosphoryl group from activated HK to RR’s conserved aspartate (Asp).
Typically, upon phosphorylation, RR undergoes conformational change, and RR’s
output domain which is most frequently a helix-turn-helix DNA-binding domain, changes
its affinity to specific DNA elements so as to modify DNA transcription. (68, 69). Other
types of RR output domain include those with enzymatic functions, for example,
GGDEF diguanylate cyclases, EAL c-di-GMP phosphodiesterases, and CheB-like
methylesterases (70). Except for being a kinase, some HKs also function as
phosphatase that it can catalyze dephosphorylation of RR, where phosphoryl group is
transferred to water, and the whole system returns to pre-activation state. In a more
complex scheme, an HK may contain multiple signal transducing domains, including
one or more Asp-containing receiver domains at the C- terminus. This kind of HK is
usually known as a “hybrid” protein. In other cases, more proteins are involved in the
multiple phosphotransfer processes which is called a phosphorelay.

TCSs can be found in all domains of organism, and it is one of the most prevalent
systems in prokaryotes. The number of TCSs vary greatly in different microbes, ranging
from 0 in
Mycoplasma genitalium to 80 in Synechocystis spp (71, 72). In the V. parahaemolyticus,
it is predicted through genome sequencing alignment that it contains more than 50 pairs
of HKs and RRs. Genes of functionally coupled HKs and RRs are often encoded
adjacent to one another, forming an operon. And this arrangement is always an
indicative of a cognate TCS (70). Interestingly, cross-talks between two or more TCSs
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do have been observed in many studies. In a study that covered transcriptome analysis
of all the TCSs in E.coli, it was found that the overall TCSs form a network of functional
interactions. For example, cellular functions such as flagellar synthesis and expression
of the RpoS regulon were affected by multiple two-component systems (73); on the
contrary, one TCS always simultaneously monitor multiple environmental signals and
affect transcriptional level of many different genes. In some cases, a HK can
phosphorylate a non-cognate RR when the cognate RR is mutated and non-functional
(74).

Many virulence and antibiotic resistance gene are regulated by TCSs in pathogens. For
example, in Salmonella typhimurium, strains with phoP(HK) or phoQ (RR) mutations
have decreased survival in cultured mouse macrophages (75). PhoP-PhoQ TCS is also
involved in resistance of antimicrobial peptides by monitoring periplasmic
concentrations of Mg2+ and the sub-lethal concentrations of antimicrobial peptides itself
(76, 77). In enterohemorrhagic Escherichia coli (EHEC) O157:H7, the expression of a
conserved pathogenicity island known as locus of enterocyte effacement (LEE) is under
control of quorum sensing. The autoinducer 3 (AI-3) directly activate the TCS of QseCQseB and controls LEE1 gene expression. The QseC-QseB also controls expression of
other virulence genes such as flagella and motility genes (78, 79). In gram positive
bacteria, VanS (HK) directly binds to vancomycin, leading to the expression of genes
that are required for the synthesis of alternate peptidoglycan precursors that have low
affinity for vancomycin (80-82). Despite the evidence that TCS plays an important role in
the induction of virulence and antibiotic resistance of pathogen, it remains unclear to
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many TCSs what environmental stimuli activate the system in the first place. So far,
very few research investigated the TCSs in Vibrio spp., and no research has
investigated the role TCSs play in the virulence and antibiotic resistance of V.
parahaemolyticus.

Chapter 2. Sensor histidine kinase is a β-lactam receptor and
induces resistance to β-lactam antibiotics

2.1 Introduction
The β-lactams are the most widely used and among the most valuable classes of
antibiotics (83). These agents contain a β-lactam ring in their structures and inhibit the
activity of transpeptidases or penicillin binding proteins (PBPs), the essential enzymes
for the biosynthesis of peptidoglycan (PG) (47, 48), thereby damaging the integrity of
bacterial cell wall. One of the principal mechanisms by which bacteria develop
resistance to β-lactam antibiotics is the production of intrinsic or horizontally acquired βlactamases that can degrade and inactivate β-lactams (54).
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In many bacterial species, β-lactamase expression is inducible in response to β-lactam
antibiotic treatment. For example, in Gram positive bacteria, β-lactamase can be
induced directly by β-lactam antibiotics or indirectly by muropeptides that are released
from PG after β-lactam treatment (55). In Gram-negative bacteria (e.g.,
Enterobacteriaceae), muropeptide produced after β-lactam treatment can also induce
the expression β-lactamase(56, 84). In addition to β-lactam treatment, β-lactamase
expression in Gram-negative bacteria can also be induced by the changes of growth
rate (58, 85). The direct role of β-lactam in inducing the expression of β-lactamase in
Gram-negative bacteria has not been reported.

Two-component systems (TCSs), which are typically composed of a sensor histidine
kinase (HK) and a response regulator (RR), are widely present in many bacterial
species (86, 87). Typically, environmental signals are sensed by histidine kinase,
leading to its autophosphorylation and subsequent phosphoryl transfer to its cognate
response regulator (69, 88). Upon phosphorylation, a response regulator usually
controls the expression of genes for adaptation to changing environment. Certain TCSs
have been shown to contribute to antibiotic (e.g., glycopeptide) resistance. For example,
VanS, the histidine kinase of VanSR TCS, directly binds to vancomycin, eading to the
expression of genes that are required for the synthesis of alternate peptidoglycan
precursors that have low affinity for vancomycin (80, 81, 89). TCSs (e.g.,
BlrAB in Aeromonas or CreBC in Escherichia coli and Pseudomonas) have also been
shown to be involved in the expression of β-lactamase and thus are important for βlactam resistance (3, 9, 18). The response regulator of BlrAB or CreBC triggers the
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expression of β-lactamase by recognizing the signature sequences (cre/blr-tag:
TTCACnnnnnnTTCAC) located in the promoter of β-lactamase gene (48, 85, 90).
Despite the evidence that TCS plays an important role in the induction of β-lactamase
expression, the identity of the cues that are recognized and transmitted by TCS to
control β-lactamase expression remain completely unknown (91).

Here, we reported a previously unidentified mechanism that governs β-lactamase
production in Gram-negative bacterium Vibrio parahaemolyticus, the leading cause of
seafood-borne diarrheal disease worldwide. Most isolates of V. parahaemolyticus from
both clinical and environmental settings exhibit resistance to β-lactam antibiotics,
thereby limiting treatment options. At the time we initiated these studies, there was
minimal knowledge of the mechanisms underlying V. parahaemolyticus resistance to βlactam antibiotics. However, a recent report revealed that essentially all V.
parahaemolyticus isolates encode a class A chromosomal carbenicillin-hydrolyzing
(CARB) β-lactamase (blaV110) (92). We independently identified this chromosome IIencoded enzyme as part of the regulon of a novel TCS (VbrK/VbrR) that controls V.
parahaemolyticus resistance to β-lactam antibiotics. Notably, we show that the sensor
histidine kinase, VbrK, in this system detects β-lactam antibiotics via direct binding and
transmits the signal to the response regulator, VbrR, to control the expression
of this CARB β-lactamase gene.

2.2 Materials and methods
2.2.1 Strains and plasmids
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All E. coli strains were cultured in Lysogeny broth (LB) at 37 °C. WT V.
parahaemolyticus RIMD2210633 (10) was grown in LB containing 1% NaCl or in the M9
minimum medium. All deletion mutants were generated by allelic exchange using the
suicide vector pDM4. Complementation was conducted by cloning the respective genes
in the low-copy (approximately seven copies per cell) vector pMMB207. The strains and
vectors used in this study are listed in Table 1. Primers used in this study are listed in
Table 2.

2.2.2 Construction of the deletion knockouts
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2.2.2.1 Construction of the pDM4 based plasmid

All pDM4 based knockouts were generated by homologous recombination. The flanking
regions (300-500bp) of target gene were amplified by PCR. The primers for amplifying
upstream fragment are named gene number _1F and gene number _1R; the primers for
amplifying downstream fragment are named gene number _2F and gene number _2R.
Primers 1F and 2R included overlap sequences to pDM4 vector at their 5’ and 3’ end
respectively. Primers 1R and 2F included complimentary sequences at their 3’ and 5’
end. PCR reactions were carried out in 2X master mix (Thermo Scientific) that include
Taq DNA Polymerase, dNTPs, and all of the components required for PCR, except DNA
template and primers. The PCR reaction mixture was treated for 5min at 95°C, followed
by 30 cycles of 30s at 94°C, 30s at 55°C, 45s at 68°C, the reaction was ended with 5
min at 68°C. Products were examined on a 0.8% (w/v) agarose gel and purified with the
QIAquick-spin PCR purification kit (Qiagen). The purified DNA fragments were ligated
into XhoI-digested pDM4 through isothermal assembly cloning. The cloning system
include 5% PEG-8000, 100mM Tris-HCl (Ph7.5), 10mM MgCl2, 10mM DTT, 200uM
each dNTP, 1mM NAD, 20ng pDM4, and 100ng DNA fragments. The mixture was
incubated at 50°C for 60min.
Plasmids pDM4-HK1-32. The up- and downstream regions flanking 31 potential
histidine kinase genes (the ORF number is shown in Fig. S1) were amplified using
primer pairs (Table 2.2). V. parahaemolyticus RIMD 2210633 chromosomal DNA was
used as a template. The resulting product was inserted into XhoI-digested pDM4,
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resulting in plasmids of pDM4-HK1-32 (Table 2.1). These plasmids were used to
construct the deletion mutants lacking 31 histidine kinases shown in Fig.2-1 .
Plasmid pDM4-19. The up- and downstream regions flanking vpa0919 (vbrR) were
amplified using primer pairs VPA0919_1F/ VPA0919_1R and
VPA0919_2F/VPA0919_2R, respectively. The resulting product was inserted into XhoIdigested pDM4, resulting in plasmid pDM4-19 (Table 2.1). This plasmid was used to
generate vbrR deletion mutant.
Plasmid pDM4-0477. The up- and downstream regions flanking vpa0477 (blaA) were
amplified using primer pairs VPA0477_1F/ VPA0477_1R and
VPA0477_2F/VPA0477_2R, respectively. The resulting product was inserted into XhoIdigested pDM4, resulting in plasmid pDM4-0477 (Table 2.1). This plasmid was used to
generate the blaA deletion mutant

2.2.2.2 Construction of deletion mutants
Deletion mutants were generated by homologous recombination. Take ∆VbrR (∆
vpa0919) as an example. The ligation product containing plasmid pDM4-19 was
dialyzed for 15 minutes and then incubated with competent E.coli sm10 on ice for 10
minutes. The mixture was transferred into cuvettes and electroporated at voltage of
2kV. 1ml LB was then added to the mixture and incubated at 37°C for 1h before it was
plated on selective LB agar supplemented with 50ug/ml chloramphenicol. The plasmid
pDM4-19 was transferred into V. parahaemolyticus by conjugation with E.coli, resultant
transconjugants were selected by 50ug/ml carbenicillin and 50ug/ml chloramphenicol.
To complete the allelic exchange, the integrated suicide plasmid was induced to excise
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from the chromosome by growing on LB containing 10% sucrose. Chloramphenicolsensitive clones were obtained and screened by PCR with primers 1F and 2R. One
clone was selected with vpa0919 gene deletion thereafter designated as ∆ vpa0919.
Construction of other HK and blaA deletion mutants was performed in the same manner
as described above.

2.2.3 Construction of complementation strain
2.2.3.1 Construction of plasmid for complementation

Complementation was conducted by cloning the respective genes in the low-copy
(approximately seven copies per cell) vector pMMB207.
Plasmid pMMB207-19. The vbrR gene was amplified using primers
VPA0919_pMMB_F and VPA0919_pMMB_R. A 6xHis tag was added at the C terminus.
The PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting
in plasmid pMMB207-19 (Table 2.1). This plasmid was used to complement ΔvbrR and
protein expression for phosphorylation assay.
Plasmid pMMB207-20. The vbrK gene was PCR amplified using primers
VPA0920_pMMB_F and VPA0920_pMMB_R. A 6xHis tag was added at the C terminus.
The PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting
in plasmid pMMB207-20 (Table 2.1). This plasmid was used to complement ΔvbrK and
protein expression for phosphorylation assay.
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Plasmid pMMB207-20-H286A. Point mutation H286A was introduced in the coding
sequence of vbrK by PCR using primer pairs VPA0920_pMMB_F/VPA0920H286A_1R
and VPA0920H286A_2F/VPA0920 pMMB_R, respectively. A 6xHis tag was added at the C terminus.
The PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting
in plasmid
pMMB207-20-H286A (Table 2.1). This plasmid was used to express VbrKH286A protein.
Plasmid pMMB207-19-D51A. Point mutation D51A was introduced in coding sequence
of vbrR by PCR amplification from V. parahaemolyticus using primer pairs
VPA0919_pMMB_F/VPA0919- D51A_1R and VPA0919D51A_2F/VPA0919_pMMB_R,
respectively. A 6xHis tag was added at the C terminus. The PCR product was inserted
into BamHI, XbaI double-digested pMMB207, resulting in plasmid pMMB207-19-D51A.
This plasmid was used to express VbrRD51A protein.

Plasmid pMMB207-0477. The gene for blaA was PCR amplified from V.
parahaemolyticus using primers VPA0477_RBS_pMMb_F and VPA0477_pMMB_R.
The PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting
in plasmid pMMB207- 0477 (Table 2.1). This plasmid was used to complement ΔblaA.

2.2.3.2 Construction of complementation strain
Constructed vectors were cloned into E.coli sm10 and conjugated into corresponding
knockout mutants as described above. Resultant complementation strain were selected
with 50ug/ml carbenicillin and 50ug/ml chloramphenicol.
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2.2.4 Cloning of mutated and truncated VbrK proteins into expression plasmid
Plasmid pGEX-0920SD. The coding sequence for hypothetical sensor domain (amino
acids 25–240) of VbrK was PCR amplified from V. parahaemolyticus using primers
920SD_GST_FBamHI and 920SD_GST_RXhoI. The resulting PCR product was
digested with BamHI or XhoI, accordingly, and inserted into the equivalentsite of
plasmid pGEX, resulting in plasmid pGEX-0920SD (Table 2.1). This plasmid was used
to express the GST-tagged sensor domain of VbrK.
Plasmids pGEX-0920-L82A, pGEX-0920-L95A, and pGEX-0920-P125A. The point
mutation L82A/L95A/P125A was introduced into VbrK by PCR amplification using
primer pairs 920SD_GST_FBamHI/920L82A_1R and
920SD_GST_RXhoI/920L82A_2F, 920SD_GST_FBamHI/
920L95A_1R and 920SD_GST_RXhoI/920L95A_2F, and
920SD_GST_FBamHI/920P125A_1R and 920SD_GST_RXhoI/ 920P125A_2F,
respectively (Table 2.2). A 6xHis tag was added at the C terminus of each mutant. The
resulting PCR products were digested with BamHI or XhoI, accordingly, and inserted
into the equivalent site of plasmid pGEX, resulting in plasmids pGEX0920-L82A, pGEX-0920-L95A, and pGEX-0920-P125A (Table 2.1). These plasmids
were used to express GST-VbrKL82A, GSTVbrKL95A, and GST-VbrKP125A.

2.2.5 Preparations for RNA-sequencing and RNA-seq analysis

22

RNA-seq was performed as described in (93). Bacteria were grown in LB supplemented
with 50 μg/mL carbenicillin for 3 h. Total RNA was isolated by RNEasy kit (Qiagen)
according to the manufacturer’s instruction. RNA samples were treated with DNase,
followed by the removal of rRNA using the RiboZero kit for Gram-negative bacteria
(Epicentre). Bacterial mRNA was fragmented to yield fragments in the range of 60–200
nt. The fragmented RNA and random primers were used for the synthesis of first-strand
cDNA. Second strand cDNA was synthesized subsequently. Libraries for Illumina
sequencing were generated by adding Illumina-specific adaptors to cDNA. Reads from
Illumina sequencing were aligned to chromosomes I and II of V. parahaemolyticus. The
total number of reads that can be aligned to the genome was calculated. Subsequently,
total reads per gene were normalized by RPKM [(reads/kb of gene)/(million reads
aligning to genome)] (94). DEseq, a program that was developed to analyze the
statistical differences in gene expression (95) was used to identify differentially
expressed genes between WT and ΔVbrK strains.

2.2.6 RNA extraction and RT-PCR
Bacteria were grown in LB supplemented with or without 50 μg/mL carbenicillin for 3 h.
Total RNA was isolated by RNEasy kit (Qiagen) according to the manufacturer’s
instruction. RNA samples were treated with DNase at 37°C to remove any DNA
contamination. First strand of cDNA was synthesized by SuperScript™ III First-Strand
Synthesis System (Invitrogen), and following PCR was performed using blaA-specific
primers (Table 2.2). and secY was used as an internal control.
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2.2.7 β-Lactamase activity assay.
β-Lactamase activity was quantified based on hydrolysis of nitrocefin. Bacteria were
subcultured in LB for 3 h in the presence of carbenicillin (50 μg/mL), and an equal
amount of bacterial cells were pelleted, resuspended in PBS, and sonicated. Cell lysate
was incubated with 50 μg/mL nitrocefin for 30 min at room temperature before OD490
was measured. To determine the effect of β-lactam on β-lactamase activity, bacteria
were subcultured in M9 medium containing different concentrations of carbenicillin, and
β-lactamase activity was quantified at different time points after carbenicillin was added.
2.2.8 Phosphorylation assay
Both in vivo and in vitro phosphorylation were performed using a Phos-tag SDS-PAGE.
The Phos-tagTM added to acrylamide gel are obtained from Wako.
In vivo phosphorylation assay
For in vivo phosphorylation, bacterial strains harboring VbrK or VbrR vectors were
grown
in LB or M9 with or without treatment of carbenicillin (50 μg/mL). Following 3 h of
treatment, whole-cell lysate was obtaining by sonication and resolved in 12% (wt/vol)
SDS gels (29:1) containing 50 μM Phos-tag acrylamide and 100 μM MnCl2. Proteins in
the Phos-tag gels were transferred onto a nitrocellulose membrane, and protein mobility
shift was determined by Western blot using anti-His antibody.
In vitro phosphorylation assay
For in vitro phosphorylation, E. coli DH5α harboring plasmids encoding WT or mutant
VbrK constructs were grown in LB at 37 °C, and protein expression was induced by 1
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mM IPTG for 3 h with shaking. Following centrifugation (5,000 x g) for 5 min, the cell
pellet was resuspended in lysis buffer [50 mM Tris (pH 8.0), 200 mM NaCl, and 5 mM
MgCl2], and lysed by sonication. Cell lysates were centrifuged for 30 min at 9,300 x g to
remove the cell debris, and the cleared supernatant was ultracentrifuged at 180,000 x g
for 1 h. Kinase buffer containing 50 mM Tris (pH 8.0), 100 mM KCl, 5 mM MgCl2, and
10% (vol/vol) glycerol was then used to resuspend the
membrane pellets. The membrane extracts containing WT VbrK or mutant VbrK were
treated with carbenicillin (50 μg/mL) or left without treatment of carbenicillin.
Subsequently, samples
were resolved in Phos-tag gels, and protein mobility shift was determined. In vitro
phosphorylation was also performed for VbrK membrane extracts treated with other
lactams, including e-caprolactam, δ-valerolactam, and 2-azacyclononanone.

2.2.9 Expression and purification of GST tagged protein
A seed culture of Escherichia coliDH5αλpir harboring plasmids encoding GST-tagged
VbrK sensor domain (GST-VbrKSD), GST-VbrKSD_L82A, or GST alone was grown
overnight in 3 ml Lysogeny broth (LB). A 1 ml aliquot from this seed culture was used to
inoculate 300ml LB supplemented with or without carbenicillin (50 μg/mL). The growth
of bacteria was allowed to continue up to an OD600 0.4, then the protein expression was
initiated with the addition of 1mM IPTG and the bacterial culture was shaken for another
2-3 hrs at 37°C. The cells were harvested by centrifugation at 5,000 x g for 5 min and
suspended in PBS (10 mM phosphate buffer pH 7.4, 150 mM NaCl). GST-tagged
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proteins were purified by glutathione- agarose (Sigma-Aldrich) as per manufacturer’s
instructions. Briefly, The soluble content of the cells was liberated via sonication, Triton
X-100 was added to the lysate to a final concentration of 1% (v/v). Cell debris were
removed by centrifugation at 13,000xg for 10 min at 4°C, the supernatant was incubated
with 2.5ml PBS- equilibrated resin in the column for 2 hours at 4°C and under gravity
flow. Resin was washed four times with PBS-T (PBS containing 1% Triton X-100) at
4°C, and GST-tagged protein is eluted by elution buffer (5 mM to 10 mM reduced
glutathione in 50 mM Tris-HCl, pH 7.5) 3 times, 1ml each. The fractions containing
GST-tagged proteins were analyzed by 12% SDS-PAGE and Coomassie blue stain.
2.2.10 Penicillin binding assay
2.2.10.1 Penicillin binding ELISA

For penicillin binding assay, purified GST - tagged proteins were coated to Polyvinyl
Chloride(PVC) microtiter plate by mixing with bicarbonate/carbonate buffer (100 mM, pH
9.6) for 2 h, followed by incubation with or without penicillin in phosphate buffer (20 mM
potassium phosphate, 40 mM sodium chloride, pH 7.5) for 1 h. Mouse monoclonal antipenicillin antibody (Fisher Scientific) and HRP-conjugated anti-mouse IgG secondary
antibody (diluted in1% BSA) were then added and incubated with protein for 1 h,
sequentially. PBC was manifested by adding HRP substrate (TMB) to each well and
measuring OD370. All incubations were carried out at room temperature and were
followed by decanting and washing with PBS containing 0.05% Tween-20 four times
before subsequent procedures.
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2.2.10.2 Penicillin binding pull-down
Pull-down assay was performed using G Sepharose beads(abcam), the steps followed
manufacture’s instructions with minor revisions. Briefly, anti-penicillin antibody and
penicillin was sequentially incubated with protein G Sepharose beads in PBS for 1h for
immobilization. Subsequently, GST-VbrKSD or GST-VbrKSD_L82A were added onto
the beads and incubated for 2 h to allow the binding between VbrK and penicillin. After
incubation, the slurry was washed with wash buffer (10mM Tris, pH 7.4, 1mM EDTA,
1mM EGTA; pH 8.0, 150mM NaCl, 1% Triton X100) 3 times to remove excessive
antibody and nonspecific binding proteins. Proteins were eluted by adding 1X protein
loading buffer (Bio-rad) analyzed by western blot using anti-GST.

2.2.11 Antibiotic susceptibility testing
Minimal inhibitory concentration(MIC) of V. parahaemolyticus to antibiotic agents was
determined using the broth dilution method in accordance with previous guidelines (96).
Briefly, two-fold serial dilutions of antibiotics in LB broth were made from 10mg/ml
antibiotic stocks. The concentration of antibiotics ranges from 1-256 ug/ml. One tube
with no antibiotic was included as a growth control. Bacteria were grown fresh and
diluted to inoculum size of 5X 105 colony-forming units (cfu)/ml, and were incubated in
the presence of antibiotics overnight (18 hours) at room temperature. The MIC was
defined as the lowest concentration of antibiotic that completely inhibited visual growth
of the bacteria. 32ug/ml is considered as a general borderline of antibiotic resistance
according to previous criteria(97).
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2.3 Results
2.3.1 V. parahaemolyticus RIMD 2210633 is resistant to multiple antibiotics
12 antibiotics belonging to 9 categories including β-lactam, macrolide, glycopeptide,
aminoglycoside, antimicrobial peptide, fluoroquinolones and tetracyclines were tested.
Based on the guideline that 32ug/ml is a borderline for antibiotic resistance (97), V.
parahaemolyticus were determined to be resistant to 7 antibiotics tested. MICs toward
these antibiotics are as follows: strepytomycin(64ug/ml), kanamycin (32ug/ml),
erythromycin (64ug/ml), vancomycin (256ug/ml), polymyxinB(32ug/ml),
carbenicillin(>256ug/ml), ampicillin(>256ug/ml) and spectiomycin (128ug/ml).

2.3.2 Identification of a Histidine Kinase That Is Essential for V. parahaemolyticus
Resistance to β-Lactams.
V. parahaemolyticus isolated from both environmental and clinical settings are routinely
resistant to β-lactam antibiotics. As part of an ongoing project to characterize the roles
of V. parahaemolyticus’ TCSs, we attempted to delete all 32 of thepredicted histidine
kinases encoded in the pathogen’s genome. 31 mutants were successfully created,
each containing a deletion of an individual ORF encoding a putative histidine kinase.
Notably, it was found that one of the mutants, harboring a deletion of vpa920, could not
grow on LB agar plates containing carbenicillin (Fig.2-1A), ampicillin, or penicillin (Fig.
2-1B). Complementation of the
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Δvpa0920 mutant with a wild-type vpa0920 in trans restored resistanceto carbenicillin
(Fig. 2-1C), indicating that vpa0920 is important for carbenicillin resistance. These
results indicate that the predicted histidine sensor kinase vpa0920 (now designated as
VbrK for Vibrio β-lactam resistance sensor kinase) is essential for V. parahaemolyticus
β-lactam resistance. VbrK is composed of 484 aa, of which amino acids 14–275 contain
the domain of DUF3404 with unknown functions. The region encompassing amino acids
274–332 is predicted to be the histidine kinase (HisKA) domain, and the region from
amino acids 390–475 is the ATPase
domain. VbrK is present in all Vibrio species with 60–90% sequence identity across the
species. VbrK is predicted to be a membrane protein with two potential transmembrane
regions located at amino acids 9–16 and amino acids 240–260, respectively (Fig. 2-2A).
Amino acids 25–240 are predicted to be located extracellularly, whereas amino acids
261–484 are predicted to be located intracellularly. We expressed VbrK with a Cterminal 6xHis tag in ΔvbrK, and our results showed that VbrK_6xHis was exclusively
present in the membrane extracts (Fig. 2-2B), experimentally demonstrating that VbrK is
a membrane protein. In the downstream of vbrK, there is an ORF (vpa0919) encoding
predicted response regulator (designated as vbrR for Vibrio β-lactam resistance
response regulator). As expected, VbrR_6xHis is a cytosolic protein (Fig. 2-2B).

2.3.3 Identification of Genes That Are Regulated by VbrK.
We carried out RNA sequencing (RNA-seq) experiments to identify the VbrK regulon,
with the ultimate goal of elucidating the mechanisms by which this histidine kinase
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regulates β-lactam resistance. In these experiments, we compared the transcriptomes
of wild-type and ΔvbrK V. parahaemolyticus grown in LB. We found that 230 (4.9%) and
235 (5.0%) of the 4,868 annotated V. parahaemolyticus ORFs were significantly up- and
down-regulated (more than
threefold), respectively, in the ΔvbrK strain compared with WT. To gain insight into the
pathways that are regulated by VbrK, we grouped the differentially expressed genes
based on their GO annotations. This analysis revealed that several GO categories were
significantly reduced (more than twofold) in the ΔvbrK mutant compared with the WT,
including those involving peptidoglycan biosynthesis, vancomycin resistance, pyruvate
metabolism, and β-lactam resistance (Fig. 2-3 and Table 2-3). Genes in the β-lactam
resistance category include vp0040 encoding TetR transcriptional factor, vp0039
encoding HlyD membrane fusion protein,
vp0454 encoding penicillin binding protein 3, vp0545 encoding β-hexosaminidase,
vp2751 encoding penicillin binding protein 1A, and vpa0477 encoding a class A βlactamase. The latter gene had the largest fold change ( 3.5 folds) between the WT and
ΔvbrK mutant, and encodes a class A CARB β-lactamase (blaA) with 98.36% identity in
nucleotide sequence and 98.59%
identity in amino acid sequences to the recently described blaV110(92). We performed
RT-PCR analyses to verify that blaA is regulated by VbrK. Notably, expression of blaA
was dependent on
VbrK; we observed blaA expression in the WT strain (Fig. 2-4A, lanes 1 and 2), but not
in the ΔvbrK strain (Fig. 2-4A, lanes 3 and 4). Complementation of ΔvbrK with the WT

30

vbrK gene in trans restored the expression of blaA (Fig. 2-4A, lanes 7 and 8), indicating
that VbrK is essential for the expression of blaA.

2.3.4 VbrK Is Essential for V. parahaemolyticus β-Lactamase Activity.
Because VbrK is critical for the expression of blaA (Fig. 2-4 A), and blaA is predicted to
encode a β-lactamase, we hypothesized that VbrK is also essential for β-lactamase
activity. β-Lactamase activity was determined by measuring the ability of bacterial cell
lysate to hydrolyze the substrate nitrocefin, which rapidly changes color from yellow to
red upon degradation. As seen in Fig. 2-4 B, lysates from WT hydrolyzed nitrocefin
yielding a red color (Fig. 2-4 B) detectable as an increase in OD490 (Fig. 2-4C),
whereas the lysate from the ΔvbrK mutant did not hydrolyze nitrocefin (Fig. 2-4 B),
yielding a baseline OD490 indistinguishable from a ΔblaA mutant (Fig. 2-4C).
Complementation of the ΔvbrK mutant with a WT vbrK gene in trans restored the
strain’s ability to hydrolyze nitrocefin (Fig. 2-4 B and C) demonstrating that VbrK is
essential for V. parahaemolyticus β-lactamase activity. Furthermore, deletion of blaA
abolished β-lactamase activity (Fig. 2-4 B and C) and β-lactam resistance (Fig. 2-5).
However, expression of blaA in the ΔvbrK mutant restored the strain’s ability to produce
β-lactamase and resist β-lactam antibiotics (Fig. 2-4 B and C). Thus, these observations
strongly suggest that VbrK controls β-lactam resistance via regulating the expression of
blaA that encodes a functional β-lactamase.
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2.3.5 Transcription of blaA and production of β-Lactamase require β-Lactam
treatment.
We have shown that blaA is expressed in a VbrK dependent fashion when V.
parahaemolyticus is grown in LB containing carbenicillin (Fig. 2-4). We hypothesized
that blaA transcription is regulated by β-lactams. To eliminate the confounding factors in
LB, we grew WT in minimum (M9) medium with or without carbenicillin and determined
the expression of blaA by RT-PCR. The results showed that blaA was transcribed in the
presence of carbenicillin, whereas it was not transcribed in the absence of carbenicillin
(Fig. 2-6A). We further showed that β-lactamase activity in WT was controlled by
carbenicillin in a dose-dependent manner (Fig. 2-6B and Fig. 2-7A). In addition to
carbenicillin, β-lactamase activity can also be induced by other β-lactams, including
ampicillin and penicillin (Fig. 2-7B). We used 50 μg/mL carbenicillin in subsequent
studies. β-Lactamase activity was gradually increased from 0 to 3 h after β-lactam was
supplied
(Fig. 3C and Fig. 2-7C), indicating that β-lactamase activity was controlled by
carbenicillin in a time-dependent manner. Although β-lactamase activity is only slightly
increased at 1 h after carbenicillin was added, such an increase was sufficient to trigger
β-lactam resistance, because the growth curve of WT in the presence of carbenicillin
was similar to that in the absence of carbenicillin (Fig. 2-7F), whereas cfu of ΔvbrK was
decreased in the presence of carbenicillin (Fig. 2-7F) in the first hour of growth. These
results suggest that carbenicillin triggers VbrK-dependent β-lactam resistance quickly
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(as early as 10 min after carbenicillin was added). β-Lactams contain a four-ring atom
structure, whereas other lactams contain five-ring atoms (γ-lactam), six-ring atoms (δlactam), seven-ring atoms (e-lactam), and nine-ring atoms (Fig. 2-7E). We found that βlactamase activity was only triggered by the β-lactam, but not other lactams (Fig. 2-6D
and Fig. 2-7D).

2.3.6 VbrK Can Be Phosphorylated on Its Conserved Histidine Residue in Vivo.
Histidine kinases usually contain a conserved histidine residue that can be
phosphorylated, and such phosphorylation is essential for its signal transducing
function. We determined VbrK phosphorylation using Phos-tag, which preferentially
binds phosphorylated protein, retarding migration in SDS/PAGE gels (98). In this
experiment, we grew bacteria in LB with or without
carbenicillin, and whole-cell lysate was obtained for SDS/PAGE and Western blot. In the
presence of carbenicillin, a shifted band (VbrK-P) of VbrK_6xHis was detected when
proteins were separated in Phos-tag gel (Fig. 2-8A), indicating that VbrK was
phosphorylated. When the conserved histidine residue at the 286th amino acid of VbrK
was substituted with alanine (H286A), VbrK phosphorylation was abolished (Fig. 2-8A),
indicating that VbrK phosphorylation is dependent on its conserved histidine residue. In
the absence of carbenicillin, phosphorylation of VbrK was not detected (Fig. 2-8A).
Furthermore, the substitution of histidine with alanine in VbrK abolished blaA expression
(Fig. 2-4 A, lanes 9 and 10), β-lactamase activity (Fig. 2-4 B and C), and β-lactam
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resistance (Fig. 2-1C), indicating that VbrK phosphorylation is functionally important for
V. parahaemolyticus β-lactam resistance.

2.3.7 VbrK Forms a TCS with Its Response Regulator VbrR.
Deletion of vbrR, the putative response regulator located adjacent to vbrK on the
chromosome, abolished blaA gene expression (Fig. 2-4A, lanes 5 and 6), β-lactamase
activity (Fig. 2-4 B and C), and β-lactam resistance (Fig. 2-1C). Complementation of
ΔvbrR with a WT vbrR gene in trans restored the blaA gene transcription (Fig. 2-4A,
lanes 11 and 12), β-lactamase activity (Fig. 2-4 B and C), and β-lactam resistance (Fig.
2-1C), indicating that VbrR is essential for β-lactam resistance. Together, these
observations strongly suggest that VbrK and VbrR form a TCS that controls cellular
production of β-lactamase. To determine if VbrR can be phosphorylated, we expressed
VbrR_6xHis in ΔvbrR, and phosphorylation was assessed using the Phos-tag assay. A
shifted band of VbrR was observed when bacteria were cultured in the presence of
carbenicillin (Fig. 2-8 B); in contrast, the shifted band was not observed in the absence
of carbenicillin (Fig. 2-8 B), indicating that VbrR was phosphorylated in response to
carbenicillin. More importantly, when VbrR was expressed in ΔvbrK, the shifted band of
VbrR was not observed (Fig. 2-8 B), indicating that VbrR phosphorylation requires VbrK,
and VbrK and VbrR form a functional TCS regulating β-lactam resistance. To determine
if phosphorylation of VbrR is important for its function to induce β-lactamase expression,
we substituted the conserved aspartate residue at the 51st amino acid of VbrR (a
predicted phosphorylation site) with alanine and expressed the VbrRD51A protein in the
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ΔvbrR strain. As expected, D51A substitution completely eliminated the phosphorylation
of VbrR (Fig. 2-8 B). Furthermore, there was no blaA expression (Fig. 2-4A, lanes 13
and 14), β-lactamase activity (Fig. 2-4 B and C), and β-lactam resistance (Fig. 2-1C) in
the ΔvbrR:pVbrRD51A strain, indicating that VbrR phosphorylation by VbrK is essential
for β-lactam resistance.

2.3.8 Mutation in the Extracellular Region of VbrK Alters Its Recognition
Specificity for Lactams.
Because β-lactamase activity was triggered only by β-lactams (Fig. 2-6D and Fig. 2-7D),
we determined VbrK phosphorylation under these conditions. In these experiments, we
obtained whole-cell lysates of bacteria grown in M9 medium supplemented with different
lactams. Phosphorylation of VbrK was observed as early as 10 min after carbenicillin
was supplied (Fig. 2-9A). In the subsequent studies, we harvested proteins 3 h after
carbenicillin was added to get more phosphorylated proteins. VbrK was phosphorylated
when V. parahaemolyticus was treated with β-lactam, but not with other lactams (Fig. 29B), indicating that β-lactam triggers β-lactamase expression via phosphorylation of
VbrK. VbrK phosphorylation upon treatment
with β-lactam does not necessary indicate that VbrK is directly responding to β-lactam;
it is possible, e.g., that β-lactam treatment produces peptidoglycan breakdown products
(i.e., muropeptides), which serve as the trigger for VbrK phosphorylation. To test the
hypothesis that VbrK is a β-lactam receptor that directly detects β-lactam, we mutated
the conserved amino acids in the extracellular region predicted to form a pocket (Fig. 2-
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10) to serve as the signal recognition site. Single-mutation L82A in VbrK completely
abolished the ability to produce β-lactamase (Fig. 2-9F and Fig. 2-11). Furthermore,
VbrK with L82A mutation cannot be phosphorylated upon treatment with β-lactam or
other lactams (Fig. 5C), suggesting that L82 is critical for β-lactam recognition. Notably,
the mutant harboring VbrKL95A phosphorylated VbrK (Fig. 2-9D) and yielded
expression of β-lactamase (Fig. 2-9F and Fig. 2-11) in response to e caprolactam and
2-azacyclononanone in addition to carbenicillin. Similarly, the mutant harboring
VbrKP125A phosphorylated VbrK and expression of β-lactamase (Fig. 2-9 E and F and
Fig. 2-11) in response to δ-valerolactam as well as carbenicillin. Because ecaprolactam, 2-azacyclononanone, and δ-valerolactam do not produce peptidoglycan
breakdown products, but have the capacity to induce phosphorylation of VbrK
containing amino acid substitutions in its periplasmic pocket domain (Fig. 2-9 D and E),
it is unlikely that peptidoglycan breakdown products activate VbrK phosphorylation.
Taken together, these findings strongly suggest that VbrK is a bona fide β-lactam
receptor.

2.3.9 VbrK Is Phosphorylated in Vitro.
To further investigate whether VbrK is sufficient to interact with and respond (via
autophosphorylation) to β-lactams, we isolated membrane extracts from an E. coli strain
expressing VbrK. The membrane extracts were treated with both carbenicillin and ATP
in vitro and VbrK phosphorylation was assessed with the Phos-tag assay. A shifted
band of VbrK was observed when the membrane extract was treated with both
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carbenicillin and ATP; the intensity of such a shifted band was much lower without
carbenicillin treatment (Fig. 2-12A, lanes 4 and 5), indicating that carbenicillin directly
triggers the phosphorylation of VbrK. Carbenicillin-dependent phosphorylation requires
the presence of ATP (Fig. 2-12A, lane 1). Furthermore, carbenicillin did not trigger
phosphorylation of a similar membrane extract from an E. coli strain expressing
VbrKH286A (Fig. 2-12A, lanes 2 and 3), strongly suggesting that the conserved
histidine residue in VbrK is required for carbenicillin to trigger the protein’s
autophosphorylation. Treatment with other lactams did not induce the phosphorylation
of VbrK (Fig. 2-12B). Taken together, these results reveal that VbrK phosphorylation is
directly triggered by β-lactam, but not by other lactams.

2.3.10 Extracellular Sensor Domain of VbrK Directly Binds Penicillin.
To further elucidate the mechanisms by which β-lactam triggers the phosphorylation of
VbrK, we determined if penicillin can directly bind to the periplasmic sensor domain of
VbrK (amino acids 25–240, VbrKSD). We purified GST-VbrKSD, GST, and
GSTSD_L82A to homogeneity as shown by Coomassie blue staining (Fig. 2-13). A
microtiter plate was subsequently coated with these purified proteins, and penicillin
binding to the precoated microtiter plate was measured using anti-penicillin antibody
and HRP-conjugated secondary antibody. Blue color formation and increases of OD370
indicate that penicillin binds to the microtiter plate. Addition of 50 ng penicillin to the
wells precoated with GST-VbrKSD results in slight blue color formation and
approximately twofold increase of OD370 compared with the wells without addition of
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penicillin (Fig. 2-12 C and D). More significant blue color and approximately fourfold
increase in OD370 was observed when 500 ng penicillin was added (Fig. 2-12 C and
D), indicating that penicillin directly binds the VbrK sensor domain in a concentrationdependent manner. Such binding was specific because addition of penicillin to the wells
precoated with purified GST alone did not result in a significant blue color and increase
of OD370 (Fig. 2-12 C and D). Furthermore, addition of penicillin to the wells precoated
with GSTVbrKSD_L82A did not result in an increase in OD370 (Fig. 2-12 C and D),
indicating that L82A mutation in the sensor domain of VbrK abolished its binding with
penicillin. To further determine the binding between penicillin and VbrKSD, we
performed a pulldown assay in which penicillin and anti-penicillin antibody were
immobilized into a protein G Sepharose followed by addition of GST-VbrKSD or GSTVbrKSD_L82A. The results showed that the elution contained GST-VbrKSD but not
GST-VbrKSD_L82A, as detected by anti-GST antibody (Fig. 2-12E), further verifying
that the sensor domain of VbrK binds penicillin, and L82 is important for such binding.
Coupled with the results that L82A mutation abolished VbrK phosphorylation and βlactamase production in response to β-lactam treatment (Fig. 2-9 C and F), we
concluded that β-lactam triggers the phosphorylation of VbrK by directly binding to the
sensor domain of VbrK.

2.4 Discussion
In this study, we show that histidine kinase VbrK is a β-lactam receptor that triggers the
expression of β-lactamase in response to β-lactam antibiotics in a Gram-negative
bacterium V. parahaemolyticus. This conclusion was supported by the results that (i)
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deletion of VbrK or its response regulator VbrR greatly reduced the expression of βlactamase and abolished the β-lactam resistance; (ii) VbrK activation is specifically
triggered by β-lactam antibiotics, but not other lactam; and (iii) single amino acid
substitution in the predicted sensor domain of VbrK alters its specificity to lactams.
Based on these results, we propose a model in which the membrane- associated
histidine kinase VbrK directly binds β-lactam antibiotics, leading to the VbrK
phosphorylation, phosphoryl transfer to VbrR, and, ultimately, the expression of βlactamase (Fig. 2-12F).

In Gram-positive bacteria (e.g., Staphylococcus aureus and Bacillus lichenformis), βlactam resistance is mediated by the expression of β-lactamase (blaZ) or the production
penicillin binding protein 2a (PBP2a or MecA), which has low affinity for β-lactam
antibiotics(99-102). Expression of blaZ is initiated upon the direct interaction of β-lactam
with the membrane-associated β-lactam receptor (BlaR1). Here, we show that Gramnegative bacterium, V. parahaemolyticus, uses a novel β-lactam receptor VbrK to
induce the expression of β-lactamase. Although both BlaR1 and VbrK are membrane
associated and recognize β-lactam via direct binding, the subsequent signaling pathway
for β-lactamase expression is different. Upon binding to the β-lactam, BlaR1 becomes
irreversibly acylated, which results in the autoproteolytic cleavage within the cytoplasmic
domain of BlaR1. The cleaved form of BlaR1 is an active metalloprotease and can
inactivate the repressor BlaI, leading to the dissociation of BlaI from the promoter of
blaZ and consequent expression of blaZ (103, 104). In contrast, VbrK becomes
autophosphorylated upon binding to β-lactams. The phosphoryl group is subsequently
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transferred to the response regulator VbrR to control the expression of β-lactamase.
When we screened for VbrK mutants that can detect other lactams, we identified P125A
and L95A. These two substitutions may modify the β-lactam binding pocket to allow for
the recognition of other lactams, leading to the subsequent VbrK phosphorylation,
phosphoryl transfer to the VbrR, and production of β-lactamase. We also identified L82A
mutation that abolished the ability of VbrK to bind to β-lactam and induce the expression
of β-lactamase, suggesting that L82 is critical for VbrK binding to β-lactam. Alternatively,
L82A mutation may alter appropriate protein folding, leading to an inactive VbrK. βLactam binding to the pocket of VbrK may result in a conformational change that is
transmitted to the HisKA domain, leading to a closer association with the ATPase
domain and consequent phosphorylation of the histidine residue.

β-Lactamase in Gram-negative bacteria is often induced by the β-lactam-associated
perturbation of cell wall integrity(56) . In Enterobacteriaceae, this induction mechanism
is complex and involves multiple proteins and steps (56, 57). β-Lactam antibiotics
disrupt the murein biosynthesis, leading to the accumulation of muropeptides in the
periplasm. These muropeptides can be transported through the inner membrane
channel created by a membrane protein AmpG. Within the cytoplasm, muropeptides
bind the transcriptional factor AmpR, and such binding activates AmpR’s DNA binding
activity, leading to the transcription and expression of AmpC β-lactamase (105). It is
conceivable that such multistep defensive mechanisms occur at the cost of damages in
the cell wall integrity. Here, we provide evidence that Gram-negative bacterium V.
parahaemolyticus can use a histidine kinase VbrK to directly sense β-lactam antibiotics,
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leading to the production of β-lactamase. Direct sensing of β-lactam antibiotic to induce
the expression of β-lactamase could occur potentially in a rapid fashion and at no cost
of damages in the cell wall integrity, which may represent a novel mechanism to defend
against β-lactam antibiotics.

Although TCSs are present in a wide range of bacterial species, and their function in the
recognition and transduction of environmental signals has been well documented, very
few physiological signals for the histidine kinases are known. Particularly, there is only
one antibiotic, vancomycin, that has been reported to be the signal molecule for the
histidine kinase VanS (81, 82). Because of the lack of the defined signals that histidine
kinase can recognize, structural analyses of ligand–histidine kinase interactions are
very limited (87, 106, 107). Defining the ligand, β-lactam, as the signal molecule for the
histidine kinase VbrK provides molecular tools to study the structure–activity
relationship of VbrK and the mechanisms by which histidine kinase is phosphorylated
and activated. Importantly, VbrK is present in almost all Vibrio species, and the residues
(L82, L95, and P125) that are responsible for specific recognition of lactams are
conserved in different Vibrio species (Fig. 2-14). The gene encoding β-lactamase was
also found in many Vibrio species, including non-O1/non-O139 Vibrio cholerae, Vibrio
harveyi, and Vibrio alginolyticus(108, 109). These results suggest that direct recognition
of β-lactam antibiotic by VbrK is a well-conserved mechanism to induce β-lactamase
gene expression in Vibrio species. Application of β-lactamase inhibitors could potentially
reduce the prevalence of β-lactam resistance (110, 111). However, the inhibitors exhibit
variable affinity to different β-lactamases, and the efficacy may be compromised by the
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overwhelming quantity of β-lactamases they produced. Defining the VbrK/VbrR
regulatory pathway that controls the expression of β-lactamase would provide a
promising target to inhibit β-lactamase production and β-lactam resistance. Lead
compounds that can inhibit the activity of histidine kinase have been identified for a
number of TCSs (112-115). There is future promise in rationally designing VbrK
inhibitors to enhance the efficacy of β-lactam antibiotics in treating infections caused by
Vibrio species.
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TABLES

Table 2.1 Strains and plasmids
Strains

Relevant

Source

genotype/description
Vibrio parahaemolyticus

Clinical isolate

(10)

RIMD 2210633

This work

RIMD 2210633
ΔvbrK

Δvpa0920
ΔvbrR

RIMD 2210633

This work

Δvpa0919
ΔblaA

RIMD 2210633

This work

Δvpa0477
ΔvbrK:pvbrK

ΔvbrK complemented

This work

with vbrK gene located in
pMMB207
ΔvbrR:pvbrR

ΔvbrR complemented
with vbrR gene located in
pMMB207

43

This work

ΔblaA:pblaA

ΔblaA complemented

This work

with blaA gene located in
pMMB207
ΔvbrK:pblaA

ΔvbrK containing blaA

This work

gene located in
pMMB207
ΔvbrK:pvbrR

ΔvbrK containing vbrR

This work

gene located in
pMMB207
ΔvbrK:pvbrKH286A

ΔvbrK complemented

This work

with mutated vbrK
gene(H286A) located in
pMMB207
ΔvbrR:pvbrRD51A

ΔvbrR complemented

This work

with mutated vbrR
gene(D51A) located in
pMMB207
Escherichia coli

KmR, thi-1, thr, leu, tonA,

SM10λpir

lacY, supE, recA::RP4-2-

This work

Tc::Mu, λpir
Escherichia coliDH5αλpir

supE44,

This work

ΔlacU169(ΦlacZΔM15),
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recA1, endA1, hsdR17,
thi-1, gyrA96, relA1, λpir

Plasmids
pDM4-19

Plasmid for deletion of

This work

vpa0919
pDM4-20

Plasmid for deletion of

This work

vpa0920
pDM4-0477

Plasmid for deletion of

This work

vpa0477
pDM4-TCS

Plasmid for deletion of

This work

TCS genes
pMMB207-19

RBS and vpa0919

This work

sequences cloned into
pMMB207
pMMB207-20

vpa0920 sequence

This work

cloned into pMMB207
pMMB207-0477

RBS and vpa0477

This work

sequences cloned into
pMMB207
pMMB207-19His

RBS and vpa0919
sequences with 6His
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This work

amino acid sequences
cloned into pMMB207
pMMB207-20His

vpa0920 sequences and

This work

6His amino acid
sequences cloned into
pMMB207
pMMB207-20-H286A

vpa0920 sequences with

This work

a point mutation in
histidine 286 and
sequences for 6His
amino acid cloned into
pMMB207
pMMB207-19-D51A

vpa0919 sequences with

This work

a point mutation in
aspartic acid 51 and
sequences for 6His
amino acid cloned into
pMMB207
pGEX-0920SD

Sequences of vpa0920

This work

sensor domain cloned
into pGEX
pGEX-0920-L82A

Sequences of vpa0920
with a point mutation in
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This work

leucine 82 cloned into
pGEX
pGEX-0920-Y71A

Sequences of vpa0920

This work

with a point mutation in
tyrosine 71 cloned into
pGEX
pGEX-0920-L95A

Sequences of vpa0920

This work

with a point mutation in
leucine 95 cloned into
pGEX
pGEX-0920-P125A

Sequences of vpa0920

This work

with a point mutation in
proline 125 cloned into
pGEX

Table 2.2 Primers used in this study
Primer name

Sequence (5’-3’)

VPA0149_1F

GCTTATCGATACCGTCGACCCTCGATGAAAGCGCGCTGCAGTA
C

VPA0149_1R

CGACTTGAACTGCGATGCCTGGCGCCCACAGATTCTAAATAAC
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VPA0149_2F

CAGGCATCGCAGTTCAAGTCGCGGGTAACAATGAAGTGAACTC
G

VPA0149_2R

CACTAGTGACGCGTACTCGAAGAAACGTTCACGGTTACGGC

VPA0710_1F

GCTTATCGATACCGTCGACCCTCGACTTCTTCTTCGCTGATCA
AAC

VPA0710_1R

CGACTTGAACTGCGATGCCTGACTATCTAATTTGTCTACTCCG
C

VPA0710_2F

CAGGCATCGCAGTTCAAGTCGTGGATTTAAAACAGAGCTCAGG

VPA0710_2R

CACTAGTGACGCGTACTCGACACTTGAGGTAATTAAAGCGGC

VPA0736_1F

GCTTATCGATACCGTCGACCCTCGAACGAACCCAGGAGAAGG
TTG

VPA0736_1R

CGACTTGAACTGCGATGCCTGAAATGCTTCCTCTAATTGGAAA
G

VPA0736_2F

CAGGCATCGCAGTTCAAGTCGTGTGATGGTGATTGATGACC

VPA0736_2R

CACTAGTGACGCGTACTCGACAAGCACCTCTCCACTTTG

VPA0763_1F

GCTTATCGATACCGTCGACCCTCGAGCAGCTGCAATCATCCAA
ATC

VPA0763_1R

CGACTTGAACTGCGATGCCTGGATAGGATTCCAAGAAATGACT
TG

VPA0763_2F

CAGGCATCGCAGTTCAAGTCGTAAAAGTAGTCATAGTGGAAGA
TG

VPA0763_2R

CACTAGTGACGCGTACTCGACGGAACATAAAAGGATCTAAGC
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VPA0920_1F

GCTTATCGATACCGTCGACCCTCGAATGGTCTAGTAGTTCATC
ACG

VPA0920_1R

CGACTTGAACTGCGATGCCTGGGACGATAAAAACTTGGCTG

VPA0920_2F

CAGGCATCGCAGTTCAAGTCGACTGTTACCGTTACTTGTTTC

VPA0920_2R

CACTAGTGACGCGTACTCGATCTGCCTGGTCACATGAACG

VPA0965_1F

GCTTATCGATACCGTCGACCCTCGAAAGCACGCACAGGCTTG
C

VPA0965_1R

CGACTTGAACTGCGATGCCTGTAAAAGGACTCTTGAGAGAATA
G

VPA0965_2F

CAGGCATCGCAGTTCAAGTCGCTCAAGATGTTTGGATTTTTAC
G

VPA0965_2R

CACTAGTGACGCGTACTCGAATAGGGATCAGAGCGCCAC

VPA1075_1F

GCTTATCGATACCGTCGACCCTCGACAGATACCAAGGAACACG
AG

VPA1075_1R

CGACTTGAACTGCGATGCCTGCGTCCAAATTTGCCAATGAAG

VPA1075_2F

CAGGCATCGCAGTTCAAGTCGGAATAGTCTCTAATCGTGATTC

VPA1075_2R

CACTAGTGACGCGTACTCGACTGGCGTTGTTGGAAGATAAC

VPA1100_1F

GCTTATCGATACCGTCGACCCTCGATTTTCATGCGCCATGTGG
TG

VPA1100_1R

CGACTTGAACTGCGATGCCTGAGTGGCTGTTCGCTCATTTC

VPA1100_2F

CAGGCATCGCAGTTCAAGTCGTTTCCAGCACCTCTAAAATTAC

VPA1100_2R

CACTAGTGACGCGTACTCGAGTTTAAACGCGCTGGAAACC
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VPA1130_1F

GCTTATCGATACCGTCGACCCTCGAATACGCTGTTTGATATGG
GATG

VPA1130_1R

CGACTTGAACTGCGATGCCTGTGCTTTTGTGAATCGTACTTGG

VPA1130_2F

CAGGCATCGCAGTTCAAGTCGCGCCCACTTATCTCGAAATG

VPA1130_2R

CACTAGTGACGCGTACTCGATATTACAGGGATTATTGTGGCG

VPA1277_1F

GCTTATCGATACCGTCGACCCTCGAAGATTTGATGCTGCCGGG
C

VPA1277_1R

CGACTTGAACTGCGATGCCTGTTATGCGTTCCATGCATCCG

VPA1277_2F

CAGGCATCGCAGTTCAAGTCGCGGGCGAACAACGATAAAAG

VPA1277_2R

CACTAGTGACGCGTACTCGACGAGAGCTTGTGTTTTGGTG

VPA1433_1F

GCTTATCGATACCGTCGACCCTCGAAGTTTTCCCGGCTTGAGA
ATC

VPA1433_1R

CGACTTGAACTGCGATGCCTGGTTACAAAGTTTTAGTCGTGGA
C

VPA1433_2F

CAGGCATCGCAGTTCAAGTCGCCAAAATTCGATGCAGAAAC

VPA1433_2R

CACTAGTGACGCGTACTCGATTGATCATGGACGAAGCAAC

VPA1515_1F

GCTTATCGATACCGTCGACCCTCGATGCCGGACTACATGGCTT
TC

VPA1515_1R

CGACTTGAACTGCGATGCCTGGAAGTGTGAATCAGACAGATC

VPA1515_2F

CAGGCATCGCAGTTCAAGTCGCCTATCGCCTCCTCACAC

VPA1515_2R

CACTAGTGACGCGTACTCGATTGCGTCAACGGCAAGATTG

VPA1664_1F

GCTTATCGATACCGTCGACCCTCGATTTTGCTCAGCAAGCTCC
ATG
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VPA1664_1R

CGACTTGAACTGCGATGCCTGGACTATGAACAAACTGGCATTC

VPA1664_2F

CAGGCATCGCAGTTCAAGTCGAAGGGAGGGTTTGAAAGAAAG

VPA1664_2R

CACTAGTGACGCGTACTCGACGATGCCGACCCGTTTGAAC

VP0362_1F

GCTTATCGATACCGTCGACCCTCGAATTATGTTGCCTAAACTC
GATGG

VP0362_1R

CGACTTGAACTGCGATGCCTGGACTCTCTTCGAGTTTGTAGC

VP0362_2F

CAGGCATCGCAGTTCAAGTCGAAGGCAAACCTTGGCTTGCC

VP0362_2R

CACTAGTGACGCGTACTCGATTTGAAAGCAGTGGCCTGGC

VP0487_1F

GCTTATCGATACCGTCGACCCTCGATTCTTCAGACTGCGTGGC
TC

VP0487_1R

CGACTTGAACTGCGATGCCTGTCACTACTCCATGGCACAAG

VP0487_2F

CAGGCATCGCAGTTCAAGTCGCATGAAGAAACTTGCACCCG

VP0487_2R

CACTAGTGACGCGTACTCGATGGTGACTTAGAAGACTAATTC

VP1069_1F

GCTTATCGATACCGTCGACCCTCGAATCGTACAACATGGTAAG
AGAG

VP1069_1R

CGACTTGAACTGCGATGCCTGATCTGTAGACGAATCATTCCC

VP1069_2F

CAGGCATCGCAGTTCAAGTCGTATACAGGTAAAAAAGCAGTCC

VP1069_2R

CACTAGTGACGCGTACTCGACGGCATGACGAATACAAAATG

VP1201_1F

GCTTATCGATACCGTCGACCCTCGAGCAGCAGCATCCACTATT
AC

VP1201_1R

CGACTTGAACTGCGATGCCTGCACCTACATCAAATGTTGTCC

VP1201_2F

CAGGCATCGCAGTTCAAGTCGTCTTTGTCCACTTTATATCGTTG
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VP1201_2R

CACTAGTGACGCGTACTCGAATAGTGCGAAGCGAAACACAC

VP1211_1F

GCTTATCGATACCGTCGACCCTCGATTCAGGCTTGTCCATTTG
G

VP1211_1R

CGACTTGAACTGCGATGCCTGAACGAATCACTAAAGACTCTTT
TTC

VP1211_2F

CAGGCATCGCAGTTCAAGTCGTCAGTTGATACCCTAAGCC

VP1211_2R

CACTAGTGACGCGTACTCGAGACGCGATTGTGCTCGAC

VP1375_1F

GCTTATCGATACCGTCGACCCTCGATCGCCTTATGTGGTGCTA
TTC

VP1375_1R

CGACTTGAACTGCGATGCCTGTACATGTATTACCCAATATGCC

VP1375_2F

CAGGCATCGCAGTTCAAGTCGAGAACCGTTGAATAAATGGCTG

VP1375_2R

CACTAGTGACGCGTACTCGACGAAACAGAACGTGGCTGTG

VP1503_1F

GCTTATCGATACCGTCGACCCTCGATACCGTTTAAACGTTCTG
AAAATTG

VP1503_1R

CGACTTGAACTGCGATGCCTGATCCCTCATCCTCAGAATCC

VP1503_2F

CAGGCATCGCAGTTCAAGTCGCGTAAACCAACGCCAGTTCC

VP1503_2R

CACTAGTGACGCGTACTCGATCATAAAGGTTGATTTACCACAA
C

VP1712_1F

GCTTATCGATACCGTCGACCCTCGAGCTTCACCAACAAACAAG
TCG

VP1712_1R

CGACTTGAACTGCGATGCCTGACATGGCAACGCGAGTGATG

VP1712_2F

CAGGCATCGCAGTTCAAGTCGGGTACATCCTTACCGTTAACC

VP1712_2R

CACTAGTGACGCGTACTCGACCAAATTGCCTGACTTCAATG
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VP1735_1F

GCTTATCGATACCGTCGACCCTCGAGCGTTCACTGCCGTAATT
TTG

VP1735_1R

CGACTTGAACTGCGATGCCTGGAATGTTTTTGATGGCGACG

VP1735_2F

CAGGCATCGCAGTTCAAGTCGCGAAAAAAGACGACTAAAAAGG

VP1735_2R

CACTAGTGACGCGTACTCGACAAGAATCCATAGCCCAGCG

VP1908_1F

GCTTATCGATACCGTCGACCCTCGACGTCGCGATTTTCTTACT
GC

VP1908_1R

CGACTTGAACTGCGATGCCTGTGTGGTGATCGTCGATGATC

VP1908_2F

CAGGCATCGCAGTTCAAGTCGCCTTCCCTCCATGAAACGC

VP1908_2R

CACTAGTGACGCGTACTCGAGCGTTTACGTATACAGGCGG

VP1968_1F

GCTTATCGATACCGTCGACCCTCGAGGTATGAGATTTTGCCCT
TG

VP1968_1R

CGACTTGAACTGCGATGCCTGGTTCATTCACCTGCGTATTTTG

VP1968_2F

CAGGCATCGCAGTTCAAGTCGTTGGCATTAAAACTGCTTAACT
G

VP1968_2R

CACTAGTGACGCGTACTCGAGTGAATAGCTCAAGGGATTTG

VP1984_1F

GCTTATCGATACCGTCGACCCTCGACATGCTGCCGCGCATGG

VP1984_1R

CGACTTGAACTGCGATGCCTGGCACCCGGCTCCAAGC

VP1984_2F

CAGGCATCGCAGTTCAAGTCGTTGCGATGCCGATTCCGACT

VP1984_2R

CACTAGTGACGCGTACTCGATATTGTTGAGCAGATGGTGG

VP2010_1F

GCTTATCGATACCGTCGACCCTCGAATTGCAATGCACAGCTCA
TCC
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VP2010_1R

CGACTTGAACTGCGATGCCTGCTAATCGGTATTTAGGAGCAG

VP2010_2F

CAGGCATCGCAGTTCAAGTCGTCCTTGCAGATATTCTTGTTCA
G

VP2010_2R

CACTAGTGACGCGTACTCGAATTGGCGCTTGGTTTTCAATAC

VP2478_1F

GCTTATCGATACCGTCGACCCTCGAACGGTTTGTCTGGTCGCG

VP2478_1R

CGACTTGAACTGCGATGCCTG
GGATAAGATTACAACTCGTAAAG

VP2478_2F

CAGGCATCGCAGTTCAAGTCG
ACCTCTCATAAAATACAAGCCTC

VP2478_2R

CACTAGTGACGCGTACTCGA GCGCTGAAAGCGTTAATTAATC

VP2567_1F

GCTTATCGATACCGTCGACCCTCGAGTCAATTGTTGGTCATAA
TTGAG

VP2567_1R

CGACTTGAACTGCGATGCCTGGTTATCTAATTACATCGGAGTC

VP2567_2F

CAGGCATCGCAGTTCAAGTCGGCATTCGGACTAAACTTCATAC

VP2567_2R

CACTAGTGACGCGTACTCGAAGTCTGTGGCAGAGATGAAAG

VP2859_1F

GCTTATCGATACCGTCGACCCTCGAGAAACGCTGAAGCGTCTG
C

VP2859_1R

CGACTTGAACTGCGATGCCTGTAATCCTCCTCAAGCAGCATAT
A

VP2859_2F

CAGGCATCGCAGTTCAAGTCGCTCTACAAGATTTCAGTTGATA
ATG

VP2859_2R

CACTAGTGACGCGTACTCGAGTCTTTGAACTTTTCGAAGTG
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VPA0919_1F

GCTTATCGATACCGTCGACCCTCGACAATTGGCGGAGGCAAG
TAAAGA

VPA0919_1R

CGACTTGAACTGCGATGCCTGCTGCTTGTTCCAGGCTTAC

VPA0919_2F

CAGGCATCGCAGTTCAAGTCGACTGTAGATACCCACGTACTTC

VPA0919_2R

CACTAGTGACGCGTACTCGAACTCATCAACCCAACGACG

VPA 0477_1F

GCTTATCGATACCGTCGACCCTCGACACGGCGGCAATTATCAT
CC

VPA 0477_1R

CGACTTGAACTGCGATGCCTGGCGTGGTGTTCTTCGTTCTT

VPA 0477_2F

CAGGCATCGCAGTTCAAGTCGGAACTCGAGCAACCAAGCC

VPA 0477_2R

CACTAGTGACGCGTACTCGAACAGTATCGAGCACCTGCTG

VPA0920_pMM AGCTCGGTACCCGGGGATCCTCTAGTTGATTAAACAGTTTTTG
B_F

CTCGG

VPA0920_pMM TCTCATCCGCCAAAACAGCCAAGCTTCAACGAGAAGCAGTGTC
B_R

TGTT

VPA0919_pMM GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATAGTGA
B_F

AACAGACACTGCTTC

VPA0919_pMM TCTCATCCGCCAAAACAGCCAAGCTTTATGCTTTCATCTTGTAG
B_R

CCTA

vpa0477_RBS_ GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATAATGAA
pMMB_F

AAAGTTATTCCTGTTGG

vpa0477_pMM

TCCGCCAAAACAGCCAAGCTTTAACTTTCTTTGTAGTGCTCTA

B_R
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VPA0920_pMM TCTCATCCGCCAAAACAGCCAAGCTTCAATGGTGGTGGTGATG
B_His_R

ATGTACGAGAAGCAGTGTCTGTT

VPA0919_pMM TCTCATCCGCCAAAACAGCCAAGCTTTAATGGTGGTGGTGATG
B_His_R

ATGATGTGCTTTCATCTTGTAGCCTA

VPA0920H286

AGCCGTTAAGATCTGTAAGAC

A_1R
VPA0920H286

GTCTTACAGATCTTAACGCTGAGCTTCGAACGCC

A_2F
VPA0919D51A

AGCTAGGATGACAAGATCCG

_1R
VPA0919D51A

CGGATCTTGTCATCCTAGCTCGCCAGCTACCTG

_2F
VPA0477_RT_

GCGACATGGACAGCGGCAA

F
VPA0477_RT_

AATCGGTCAAGTCGCGTTGC

R
secY_RT_F

GGCATCATGCCGTATATTTCG

secY_RT_R

GGCAATCCAGCAACAATACC

920SD_GST_F

AACGGATCCCTACCAGAACGCATAGATACG

BamHI
920SD_GST_R AACCTCGAGGTGATCTTCTACATCCCAAC
XhoI
920L82A_1R

CAGCGCAGCGAATACATGTC
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920L82A_2F

GACATGTATTCGCTGCGCTG

920P125A_1R

CACGCAGGTGGCGGTACTTAC

920P125A_2F

GTAAGTACCGCCACCTGCGTG

920L95A_1R

CCTGCAATTACTGAACCTCTAG

920L95A_2F

CTAGAGGTTCAGTAATTGCAGG

Table2.3 Members of GO groups significantly overrepresented among up- and
down-regulated genes in ΔvbrK strain (compared with WT)
GO term

No. of genes

P value

Peptidoglycan biosynthesis 10

1.15E-05

Protein export

5

0.014736

β-Lactam resistance

6

0.016001

RNA degradation

5

0.020946

Vancomycin resistance

3

0.023682

57

Pyruvate metabolism

8

0.047559

P < 0.05 was considered significantly different
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Figure 2-1. Identification of a histidine kinase that is essential for the resistance of V.
parahaemolyticus to β-lactam antibiotics.
(A) Mutants with deletion of predicted histidine kinases were streaked on LB agar plate
containing 50 μg/mL carbenicillin. (B) ORF for the predicted histidine kinase that was
deleted was shown. Deletion of vpa0920 abolished the ability of V. parahaemolyticus to
resist ampicillin and penicillin. (C) Vpa0920 was designated as VbrK. Complementation
of ΔvbrK with WT vbrK, but not mutant vbrK with point mutation H286A, restored
carbenicillin resistance. Deletion of vbrR (vpa0919) abolished the ability of V.
parahaemolyticus to resist carbenicillin. Complementation of ΔvbrR with WT vbrR, but
not mutant vbrK with point mutation D51A, restored carbenicillin resistance. Expression
of vbrR in trans in a plasmid cannot restore the carbenicillin resistance of ΔvbrK.
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Figure 2-2. VbrK is predicted to be a membrane protein. (A) The transmembrane region
is predicted to be located at amino acids 9–16 and amino acids 240–260
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(www.sbc.su.se/ miklos/DAS/). Amino acids 25–240 are extracellular, whereas amino
acids 261–484 are intracellular. (B) VbrK was expressed exclusively on the membrane,
whereas VbrR is expressed as cytosolic protein.
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Figure 2-3. RNA-seq analysis of genes that are regulated by VbrK. MA plots of relative
transcript abundance between WT and ΔvbrK. The log2 of the ratio of
abundances of each transcript between the two strains (M in y axis) is plotted
against the average log2 of abundance of that transcript in both strains (A in x
axis).
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Figure 2-4. The role of VbrK/VbrR in the expression of β-lactamase. Indicated strains
were cultured in LB. (A) RT-PCR analysis of blaA expression (Upper) with secY as
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an internal control (Lower). (B) β-lactamase activity was measured by mixing V.
parahaemolyticus whole-cell lysate with the β-lactamase substrate (nitrocefin).
Once hydrolyzed, the degraded nitrocefin compound rapidly changes color from
yellow to red. (C) OD490 was measured to reflect the relative amount of βlactamase produced by each individual bacterial strain.

Figure 2-5. blaA is required for β-lactam resistance. (A) WT is resistant to carbenicillin.
Deletion of blaA abolished carbenicillin resistance (B), whereas complementation of
ΔblaA with a wild-type blaA restored carbenicillin resistance (C).
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Figure 2-6. Regulation of blaA transcription and β-lactamase activity by β-lactam. (A)
WT V. parahaemolyticus was cultured in M9. RT-PCR analysis of the blaA transcription
in the presence or absence of carbenicillin. (B) The activity of β-lactamase activity in WT
V. parahaemolyticus treated with increasing dose of carbenicillin. (C) β-Lactamase
activity was measured at different time points after carbenicillin was added. (D) βLactamase activity in WT V. parahaemolyticus
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treated with β-lactam and other lactams including e-caprolactam,δ-valerolactam, and 2
azacyclononanone.

FIgure 2-7. Regulation of β-lactamase activity by VbrK/VbrR and carbenicillin. (A) βLactamase as indicated by the color change from yellow to red in WT V.
parahaemolyticus treated with different doses of carbenicillin. (B) β-Lactamase
activity in WT V. parahaemolyticus treated with ampicillin and penicillin. (C) β-
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Lactamase was activated by carbenicillin in a time-dependent manner. (D) βLactamase was activated only by β-lactam, and not by other lactams. (E) The
structures of β-lactam, e-caprolactam, δ-valerolactam, and 2-azacyclononanone
are shown. (F) Growth curve of WT and ΔvbrK in LB in the presence or absence
of carbenicillin.

Figure 2-8. The role of β-lactam in the phosphorylation of VbrK and VbrR when V.
parahaemolyticus was cultured in LB. (A) Phosphorylation analysis of VbrK or
VbrKH286A in the indicated strains in the presence or absence of carbenicillin.
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(B) Phosphorylation analysis of VbrR or VbrRD51A in the indicated strains in the
presence or absence of carbenicillin.
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Figure 2-9. Identification of VbrK amino acid residues essential for specific recognition
of different lactams. Indicated strains were cultured in M9. (A) VbrK phosphorylation
was measured at different time points after carbenicillin was added to the culture.
Phosphorylation of VbrK (B), VbrKL82A (C), VbrKL95A (D), and VbrKP125A (E) in
V. parahaemolyticus in the presence of carbenicillin (lane 2), e-caprolactam (lane
3), δ-valerolactam (lane 4), and 2-azacyclononanone(lane 5) or in the absence of
any lactams (lane 1). (F) Indicated strains were untreated (black bar) or treated
with carbenicillin (green bar), e-caprolactam (gray bar), δ-valerolactam (yellow
bar), and 2-azacyclononanone (blue bar), and OD490 was measured to indicate βlactamase activity.
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Figure 2-10. The extracellular portion of VbrK (amino acids 25–240) was predicted
by Phyre2 (www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index) to have a pocket
domain. The amino acids that form the pocket are highlighted in red. These amino
acids highlighted in red include Y71, D75, I76, Q78, L79, L82, L95, I96, T97, P99,
L100, and P125.
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Figure 2-11. β-Lactamase activity of various strains (shown on right) of V.
parahaemolyticus in response to the treatment of β-lactam (carbenicillin) and other
lactams. The color change from yellow to red indicates the ability of whole-cell lysate to
hydrolyze nitrocefin.
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Figure 2-12. In vitro analysis of VbrK phosphorylation and interaction between VbrK and
β-lactam. (A) Membrane extracts from E. coli expressing 6xHis-tagged VbrK (lanes 4
and 5) or VbrKH286A (lanes 2 and 3) were treated with carbenicillin (lanes 3 and 5) or
left without treatment of carbenicillin (lanes 2 and 4). No addition of ATP was used as a
negative control (lane 1). Following treatment, each sample was resolved in the Phostag gel (Upper) or regular gel (Lower) and blotted with anti-His antibody. (B) In vitro
phosphorylation assay for VbrK treated with carbenicillin (lane 1), e-caprolactam (lane
2), δ-valerolactam (lane 3), and 2-azacyclononanone (lane 4). (C and D) Analysis of
binding between the VbrK sensor domain (VbrKSD) and penicillin. Microtiter plate was
precoated with GST-VbrKSD, GST-VbrKSD_L82A, or GST, or without protein coating.
Penicillin (50 ng or 500 ng) was added to the precoated plate. Following sufficient
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washing, anti-penicillin antibody and HRP secondary antibody were added. Blue color
formation was observed (D) and OD370 was measured (C) to reflect the relative
amount of penicillin that binds to the coated proteins. (E) Pulldown assay was
performed
by addition of equal amount of GST-VbrKSD (lane 2) or GST-VbrKSD_L82A (lane 1)
into the protein G Sepharose immobilized with penicillin and anti-penicillin antibody. (E)
After sufficient washing, protein elution was probed with anti-GST antibody. (F)
Schematic model for VbrK/VbrR-mediated β-lactamase expression.

Figure 2-13. Purification of VbrK sensor domain. E. coli strains containing the vectors
that express GST-VbrKSD, GST-VbrKSD_L82A, or GST alone were subcultured in LB
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for 1h, followed by addition of 1 mM IPTG for protein expression. The protein was
purified and resolved in SDS/PAGE and stained by Coomassie blue. An equal amount
of each protein was used to coat the microtiter plate.

Figure 2-14. Alignment of the sensor domain of VbrK (amino acids 1–240) from different
Vibrio species. Amino acids in the red boxes are these that govern the specificity of
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sensing β-lactams. Amino acids with an asterisk (*) at the bottom are identical across
different Vibrio species.

Chapter 3. Histidine Kinase Activated by Multiple Signals and Mediates
Resistance to Antimicrobial Peptide and Vancomycin
3.1 Introduction
Antimicrobial peptides (AMPs) are unique in that they are amphipathic so that they can
partition into phospholipid bilayer and destruct bacterial cell membrane. AMPs exist in
broad domain of life including bacteria, fungi, and human. For example, cathelicidin LL37 is widely expressed by many different types of cells including epithelium, T cells and
B cell, and plays important role in both innate and adaptive immunity (116). AMPs of
bacterial origin (Bacillus polymyxa) such as polymyxin B and polymyxin E have been
obtained for clinical use, and is recognized as the last resort antibiotics for the treatment
of gram negative pathogen infection, especially for the multidrug resistant strains (117).
Pathogens have developed various mechanisms to fight against AMP, one of the
principal mechanisms is through modification of lipopolysaccharides (LPS). As LPS is
anionic due to phosphate group attached to lipid A, AMPs can replace cationic ions that
stabilize the LPS, and insert into outer membrane. The modified LPS carries reduced
negative charges, thus become more resistant to the disturbance of AMP brings up.
Gram negative pathogens have developed different schemes of LPS modification, many
of which are regulated by two component systems(TCSs). For example, the famous
PhoP/PhoQ system in Salmonella can be activated by acidic pH, specific AMPs or

75

depletion of Mg2+ or Ca2+, and leads to subsequent expression of pagP and pagL that
acylate or deacylate lipid A (118). In P. aeruginosa,PhoP/PhoQ system can upregulate
expression of Ara4N synthesis operon and stimulate Arap4N addition to lipid A. Despite
the evidence that TCS plays an important role in the induction of LPS modification and
that Mg2+ and C18G (a human platelet factor), there is no direct evidence that correlates
the environmental stimulation to HK phosphorylation and the resultant development of
AMP resistance.
Vibrio parahaemolyticus is the leading cause of seafood-borne diarrheal disease
worldwide. The emergence of multi-drug resistant V.parahaemolyticus is making the
treatment more and more challenging. At the time we initiated these studies, there was
minimal knowledge of the mechanisms underlying V. parahaemolyticus resistance to
AMPs. Although one proteomic study suggested that V.parahaemolyticus might obtain
their resistance against AMPs through upregulation of multidrug efflux transporter or
effective repair of damaged membranes, no gene or mechanism has been confirmed
(128). Here, we reported an unidentified mechanism in Vibrio parahaemolyticus by
showing direct evidence that low Mg2+ concentration or AMP stimulate the
phosphorylation of HK, and leads to expression of enzyme that modifies LPS.

3.2 Material and methods
3.2.1 Construction of plasmids
All deletion mutants were generated by allelic exchange using the suicide vector pDM4
as described in chapter 2. Complementation was conducted by cloning the respective
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genes in the low-copy (approximately seven copies per cell) vector pMMB207 as
described in chapter 2.

Plasmid pDM4-1276. The up- and downstream regions flanking vpa1276 (pvrR) were
amplified using primer pairs VPA1276_1F/ VPA1276_1R and
VPA1276_2F/VPA1276_2R, respectively. The resulting product was inserted into XhoIdigested pDM4, resulting in plasmid pDM4-1276 (Table 3.1). This plasmid was used to
generate pvrR deletion mutant.

Plasmid pDM4-1280. The up- and downstream regions flanking vpa1280 (eptA) were
amplified using primer pairs VPA1280_1F/ VPA1280_1R and
VPA1280_2F/VPA1280_2R, respectively. The resulting product was inserted into XhoIdigested pDM4, resulting in plasmid pDM4-1280 (Table 3.1). This plasmid was used to
generate eptA deletion mutant.
Plasmid pDM4- 1279/1280. The up- and downstream regions flanking vpa1279vpa1280 (dgkA-eptA) were amplified using primer pairs VPA1279_1F/ VPA1279_1R
and VPA1280_2F/VPA1280_2R, respectively. The resulting product was inserted into
XhoI-digested pDM4, resulting in plasmid pDM4-1279/1280 (Table 3.1). This plasmid
was used to generate dgkA-eptA double-deletion mutant.
Plasmid pDM4-1277H221A. The up- and downstream regions flanking vpa1277 (pvrK)
were amplified using primer pairs VPA1277_1F/ 1277H221A_PDM4_R and
1277H221A_PDM4_F /VPA1277_2R, respectively. The resulting product was inserted
into XhoI-digested pDM4, resulting in plasmid pDM4-1277H221A (Table 3.1). This
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plasmid was used to generate pvrKH221A single amino acid mutant. The resulting mutant
was confirmed by primer set 1277H221A_CPM_F/ 1277H221A_CPM_R.
Plasmid pDM4-1276D58A. The up- and downstream regions flanking vpa1276 (pvrR)
were amplified using primer pairs VPA1276_1F/ 1276D58A_PDM4_R and
1276D58A_PDM4_F /VPA1276_2R, respectively. The resulting product was inserted
into XhoI-digested pDM4, resulting in plasmid pDM4-1276D58A (Table 3.1). This
plasmid was used to generate pvrRD58A single amino acid mutant. The resulting mutant
was confirmed by primer set 1276D58A_CPM_F/ 1276D58A_CPM_R.

Plasmid pMMB207-1276. The pvrR gene was amplified using primers
VPA1276_PMMB_RBS_F and VPA1276_PMMB_HIS_R. A 6xHis tag was added at the
C terminus. The PCR product was inserted into BamHI, XbaI double-digested
pMMB207, resulting in plasmid pMMB207-1276 (Table 3.1). This plasmid was used to
complement ΔpvrR and protein expression for phosphorylation assay.
Plasmid pMMB207-1277. The pvrR gene was amplified using primers
VPA1277_PMMB_RBS_F and VPA1277_PMMB_HIS_R. A 6xHis tag was added at the
C terminus. The PCR product was inserted into BamHI, XbaI double-digested
pMMB207, resulting in plasmid pMMB207-1276 (Table 3.1). This plasmid was used to
complement ΔpvrK and protein expression for phosphorylation assay.
Plasmid pMMB207-1280. The gene for eptA was PCR amplified from V.
parahaemolyticus using primers VPA1280_RBS_pMMB_F and
VPA1280_PMMB_HIS_R. The PCR product was inserted into BamHI, XbaI double-
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digested pMMB207, resulting in plasmid pMMB207- 1280 (Table 3.1). This plasmid was
used to complement ΔdgkA-eptA and ΔpvrK.
Plasmid pMMB207-1279. The gene for dgkA was PCR amplified from V.
parahaemolyticus using primers VPA1279_RBS_pMMB_F and
VPA1279_PMMB_HIS_R. The PCR product was inserted into BamHI, XbaI doubledigested pMMB207, resulting in plasmid pMMB207- 1279 (Table 3.1). This plasmid was
used to complement ΔpvrK.
Plasmid pMMB207-1279/1280. The gene for eptA was PCR amplified from V.
parahaemolyticus using primers VPA1279_RBS_pMMB_F and
VPA1280_PMMB_HIS_R. The PCR product was inserted into BamHI, XbaI doubledigested pMMB207, resulting in plasmid pMMB207- 1280 (Table 3.1). This plasmid was
used to complement ΔeptA and ΔpvrK.

Plasmid pMMB207-1277-H221A. Point mutation H221A was introduced in the coding
sequence of pvrK by PCR using primer pairs VPA1277_pMMB_F/VPA1277H221A_1R
and VPA1277H221A_2F/VPA1277 pMMB_R, respectively. A 6xHis tag was added at the C terminus.
The PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting
in plasmid
pMMB207-1277-H221A (Table 3.1). This plasmid was used to express PvrKH221A
protein.
Plasmid pMMB207-1276-D58A. Point mutation D58A was introduced in coding
sequence of pvrR by PCR amplification from V. parahaemolyticus using primer pairs
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VPA1276_PMMB_RBS_F /VPA1276- D58A_1R and VPA1276D58A_2F/
VPA1276_PMMB_HIS_R, respectively. A 6xHis tag was added at the C terminus. The
PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting in
plasmid pMMB207-1276-D58A. This plasmid was used to express PvrRD58A protein.
Plasmid pGEX-1277SD. The coding sequence for hypothetical sensor domain (amino
acids 28–138) of PvrK was PCR amplified from V. parahaemolyticus using primers
1277_SENDOMIN_BAMHI_F and 1277_SENDOMIN_ECORI_R. The resulting PCR
product was digested with BamHI or XhoI, accordingly, and inserted into the equivalent
site of plasmid pGEX, resulting in plasmid pGEX-1277SD (Table 3.1). This plasmid was
used to express the GST-tagged sensor domain of PvrK.

3.2.2. Construction of deletion/ single amino acid mutants and complementation
strain
The construction of deletion and single amino acid mutants are constructed using
pDM4- based plasmids (Table 3.1) as described in Chapter2.
3.2.3 RNA-seq analysis
Bacteria were grown in LB supplemented with 50 μg/mL carbenicillin for 3 h. Total RNA
was isolated by RNEasy kit (Qiagen) according to the manufacturer’s instruction. RNA
samples were treated with DNase, followed by the removal of rRNA using the RiboZero
kit for Gram-negative bacteria (Epicentre). Bacterial mRNA was fragmented to yield
fragments in the range of 60–200 nt. The fragmented RNA and random primers were
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used for the synthesis of first-strand cDNA. Second strand cDNA was synthesized
subsequently. Libraries for Illumina sequencing were generated by adding Illuminaspecific adaptors to cDNA. Reads from Illumina sequencing were aligned to
chromosomes I and II of V. parahaemolyticus. The total number of reads that can be
aligned to the genome was calculated. Subsequently, total reads per gene were
normalized by RPKM [(reads/kb of gene)/(million reads aligning to genome)]. Kabos 3.0
(119)is used to analyze KEGG pathways and involved genes that have been affected
(more than 3 times) in ΔpvrK.

3.2.4 RNA extraction and RT-PCR
Bacteria were grown in LB supplemented with or without 50 μg/mL carbenicillin for 3 h.
Total RNA was isolated by RNEasy kit (Qiagen) according to the manufacturer’s
instruction. RNA samples were treated with DNase at 37°C to remove any DNA
contamination. First strand of cDNA was synthesized by SuperScript™ III First-Strand
Synthesis System (Invitrogen), and following PCR was performed using gene-specific
primers (Table 3.2). and secY was used as an internal control.

3.2.5 Phosphorylation assay
Phostag-SDS-PAGE were used to determine the phosphorylation status of a protein.
Bacterial strains harboring PvrK or PvrR vectors were grown in LB or LB with different
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concentrations of Mg2+ or Marine broth(Difco) with treatment of carbenicillin (50 μg/mL)
and chloramphenicol (50 μg/mL). Following 3 h of treatment, whole-cell lysate was
obtaining by sonication and resolved in 12% (wt/vol) SDS gels (29:1) containing 50 μM
Phos-tag

WAKO

acrylamide and 100 μM MnCl2. After 30 minutes incubation of the

phos-tag acrylamide gel in wash buffer (25mMTris, 190mM glycin, 10mM EDTA, 20%
methanol), proteins in the Phos-tag gels were transferred onto a nitrocellulose
membrane, and protein mobility shift was determined by Western blot using HRPconjugated, anti-His antibody.

3.3 Results
3.3.1 Identification of a histidine kinase that is essential for for V.
parahaemolyticus resistance to antimicrobial peptide
As described in previous chapters, 32 TCSs of V. parahaemolyticus were identified
through gene annotation and 31 mutants were successfully created, each containing a
deletion of an individual ORF encoding a putative histidine kinase. Notably, it was found
that one of the mutants, harboring a deletion of vpa1277, exhibited increased sensitivity
toward polymyxinB, LL-37, polymyxinE and vancomycin (Fig.3-1). Complementation of
the Δvpa1277 mutant with a wild-type vpa1277 in trans restored resistance to polymyxin
B (Fig. 3-1C), indicating that vpa1277 is important for polymyxin B resistance. These
results indicate that the predicted histidine sensor kinase vpa1277 (now designated as
PvrK for Vibrio antimicrobial peptide resistance sensor kinase) is essential for V.

82

parahaemolyticus AMP resistance. PvrK is composed of 428 amino acids, of which aa
1-158 is of unknown functions. The region encompassing amino acids 158-205 is
predicted to be a HAMP domain, which is a cytoplasmic helical linker domain that is
common in histidine kinases or methyl-accepting proteins. The region from amino acids
214 to 275 is the ATPase histidine kinase A (HisKA) domain which is a phosphoracceptor, and the region from amino acids 321 to 427 is predicted to be a ATPase. PvrK
is predicted to be a membrane protein (TMHMM prediction) with two potential
transmembrane regions located at amino acids 8–21 and amino acids 140–161,
respectively (Fig. 3-2). Amino acids 28–138 are predicted to be located extracellularly,
whereas amino acids 162–428 are predicted to be located intracellularly.

3.3.2 Identification of genes that are regulated by PvrK
We carried out RNA sequencing (RNA-seq) experiments to identify the PvrK regulon,
with the ultimate goal of elucidating the mechanisms by which this histidine kinase
regulates AMP and vancomycin resistance. In these experiments, we compared the
transcriptomes of wild-type and ΔpvrK V. parahaemolyticus grown in LB. For the PvrK
regulon, transcriptomes of wild-type and ΔpvrK V. parahaemolyticus grown in LB were
compared. It was found that 120 (2.5%) and 44 (0.9%) of the 4,868 annotated V.
parahaemolyticus ORFs were significantly up- and down-regulated (more than twofold),
respectively, in the ΔpvrK strain compared with WT. KEGG pathways that were
significantly reduced (more than twofold) in the ΔpvrK mutant compared with the WT
include those involving LPS synthesis, cationic antimicrobial peptide(CAMP) resistance,
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and bacterial secretion systems and ABC transporters (Fig. 3-3). Gene in the CAMP
resistance category of PvrKR regulon include vpa1280 encoding lipid A ethanolamine
phosphotransferase (eptA), and the gene in the LPS synthesis pathway include vp2509
encoding lipid A biosynthesis lauroyl acyltransferase. Transcripts of Vp2509 decreased
6.7 times in ΔpvrK mutant while transcripts of eptA decreased 4.4 times in ΔpvrK
mutant. The gene vpa1279 was also brought into attention since it is very adjacent to
vpa1280 (22bp upstream) and its transcription level decreased by 3.8 times in ΔpvrK
mutant. It is speculated that vpa1279 might form an operon with vpa1280. Vpa 1279
encodes a diacylglycerol kinase (dagK) which catalyzes the conversion
of diacylglycerol (DAG) to phosphatidic acid (PA), utilizing ATP as a source of the
phosphate.
Except for the three genes mentioned above, the transcription level of genes predicted
to be involved in ABC transporter which include vp1999, vpa0318 and vpa0810 also
decreased more than three times in ΔpvrK. vpa0242 and vpa0243 also caught up the
attention in that transcription level of vpa0243 dropped more than 70 times while
transcription level of vpa0242 dropped 29.5 times in ΔpvrK in comparison to WT.
vpa0243 is predicted to encode a VirK protein which is periplasmic and is required for
efficient secretion of toxins in enteroaggregative Escherichia coli(EAEC) (120). I
performed RT-PCR analyses to verify that eptA and other genes are regulated by PvrK.
The transcription profile of all the tested genes are in accordance with RNA-seq results.
Notably, expression of eptA was dependent on PvrK; we observed eptA expression in
the WT strain, but not in the ΔpvrK strain (Fig. 3-4, lane 4). Transcription level of dagK
in ΔpvrK also decreased but not as obvious as of that eptA (Fig. 3-4, lane 5).
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3.3.3 Pvrk and PvrR Can Be Phosphorylated on Its Conserved Histidine Residue
In Vivo.
Histidine kinases usually contain a conserved histidine residue that can be
phosphorylated, and such phosphorylation is essential for its signal transducing
function. We determined PvrK phosphorylation using phos-tag SDS-PAGE. The
complex of phos-tag and Mn2+ ion can preferentially bind to phosphate group in a
protein, so that the migration speed of phosphorylated protein decreases and they are
separated from non-phosphorylated proteins (98). In this experiment, the bacteria is
grown in LB broth and whole-cell lysate was obtained for SDS/PAGE and Western blot.
A shifted band (PvrK-P) of PvrK_6xHis was detected when proteins were separated in
Phos-tag gel (Fig. 3-5), indicating that PvrK was phosphorylated. When the conserved
histidine residue at the 221th amino acid of PvrK was substituted with alanine (H221A),
PvrK phosphorylation was abolished (Fig. 3-5), indicating that PvrK phosphorylation is
dependent on its conserved histidine residue.

3.3.4 PvrK Genetically but Not Functionally Forms a TCS with Its Response
Regulator PvrR.
Deletion of pvrR, the putative response regulator located immediately upstream to pvrK
on the chromosome, abolished polymyxinB, polymyxinE and vancomycin resistance
(Fig. 3-1C &E). Complementation of ΔpvrR with a WT pvrR gene in trans restored
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polymyxinB, polymyxinE and vancomycin resistance, indicating that PvrR is essential
for AMP resistance. More importantly, when conserved aspartate was mutated to
alanine, the bacteria also lost its resistance to above mentioned AMPs. Together, these
observations strongly suggest that PvrK and PvrR form a TCS that controls V.
parahaemolyticus resistance to AMP and vancomycin. To determine if PvrR can be
phosphorylated, we expressed PvrR_6xHis in ΔpvrR, and phosphorylation was
assessed using the Phos-tag assay. A shifted band (PvrR-P) of PvrR_6xHis was
observed, and when the conserved aspartate residue at 58th amino acid of PvrR was
substituted with alanine (D58A), PvrR phosphorylation was abolished (Fig. 3-5),
indicating that PvrR phosphorylation is dependent on its conserved aspartate residue.
The phosphorylation assay also indirectly confirmed the hypothesis based its amino
acid sequence and predicted conformation that PvrK and PvrR are HK and RR
functionally. Surprisingly, complementation of WT PvrR into ΔpvrR or pvrRD58A barely
restored the pvrR mutants’ phenotype (Fig 3-6A). For phosphorylation assay, PvrR can
still be phosphorylated when PvrK is absent or mutated (Fig. 3-6B).
3.3.5 EptA is essential but does not fully account for AMP resistance
Because the transcription level from both vpa1279 and vpa1280 decreased in RNA-seq,
Δvpa1279-1280 and its corresponding complementation strain were created and tested
for polymyximB resistance. Deletion of both vpa1279-1280 genes abolished AMP
resistance while complementation of Δvpa1279-1280 with WT Vpa1279-80 restored the
resistance (Fig.3-7B).
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Because PvrK is critical for the transcription of eptA in RT-PCR assay (Fig. 3-4) but not
dagK, and eptA is predicted to encode a lipid A ethanolamine phosphotransferase (PEA
transferase), which adds positively charged phosphoethanolamine (PEA) to the core of
lipid A head groups and results in a less negatively charged LPS that is more resistant
to AMP disturbance. It is hypothesized that eptA is responsible for AMP resistance in V.
parahaemolyticus. To confirm this hypothesis, eptA knockout mutant was constructed
and streaked onto plates with polymyxinB. Because vpa1279 (dagK) is immediately
(22bp) upstream of eptA(vpa1280) and because its transcription dropped heavily in
RNA-seq results, constructs of ΔdagK is also generated. Both knockouts exhibited
increased sensitivity toward polymyxinB (Fig.3-7A). Complementation of either eptA or
dagK to pvrK mutant did not fully restore resistance to polymyxinB (data not shown),
implying that both genes contribute to polymyxinB resistance for the bacteria.
Complementation of both dagK and eptA to pvrK mutants fully restored polymyxinB
resistance to WT level (Fig.3-7A). Interestingly, complementation of EptA or DagK to
their respective deletion mutant cannot fully restore the polymyxinB resistance to wild
type level. One possible explanation is that the vpa1279-vpa1280 forms an operon and
deletion of a single gene destruct the promoter or terminator motifs, however, this
explanation contradicts the RT-PCR result where transcription level of eptA and dagK
was not eaxctly the same. Another explanation is that the deletion of dagK is not in
triplet frame and affected expression of eptA.

3.3.6 High Mg2+ Concentration Abolished Phosphorylation of Pvrk And
Transcription Of eptA
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As Mg2+ plays important parts in stabilizing LPS, and previous study has reported that
the PhoPQ system mediated Mg2+-dependent modifications in
lipopolysaccharides(121),we hypothesized that concentrations of Mg2+ affect PvrK
phosphorylation. The Bacteria is grown in LB, LB broth supplemented with 2mM and
10mM of Mg2+, and harvested and sonicated for Phos-tag SDS-PAGE and western blot.
A shifted band (PvrK-P) of PvrK_6xHis was detected when the protein is extracted from
V. parahaemolyticus growing in plain LB. The shifted band is thinner when PvrK was
extracted from V. parahaemolyticus growing with 2mM Mg2+ supplement. The band of
PvrK-P further faded away when V. parahaemolyticus grows with 10mM Mg2+ (Fig3-8
A). This result indicated that phosphorylation of PvrK is affected by concentrations of
Mg2+ on a dose dependent manner. To further confirm the role of Mg2+, transcriptional
level of eptA was tested under different growth conditions. In LB with high
concentrations of Mg2+, the transcriptional level of eptA plummeted in comparison to Lb
broth. Interestingly, the transcription of vpa0243, the gene that is also regulated by pvrK
and is responsible for vancomycin resistance, does not change in respond to Mg2+ level
in LB media (Fig3-8 B).

3.3.7 AMP Restored Pvrk Phosphorylation and eptA Transcription with High
Concentrations of Mg2+
Since activation of PvrK and expression of eptA is responsible for AMP resistance, we
are wondering whether AMP can reverse the phosphorylation status of PvrK with high
concentrations of Mg2+ in the environment. We grew bacteria in LB, LB with 10mM
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Mg2+, and LB supplemented with 10mM Mg2+ and sub-lethal concentrations of
polymyxin B (5ug/ml). As the shifted band (PvrK-P) of PvrK_6xHis faded away in PvrK
from 10mM Mg2+, the addition of AMP restored intensity of PvrK-P, indicating that AMP
can reverse the negative effect of high Mg2+ on phosphorylation status of PvrK (Fig.39A). Similarly, as the result of RT-PCR showed, transcription level of eptA in high
concentration(10mM) of Mg2+ is as low as that of PvrKH221A mutant, while addition of
polymyxinB restored the eptA transcription level (Fig.3-9B).

3.4 Discussion
In this study, we show that histidine kinase PvrK is activated by AMP while inhibited by
high comcentration of Mg2+ in the environment. The phosphorylation of PvrK triggers
transcription of eptA, a lipid A ethanolamine phosphotransferase and endows AMP
resistance Gram-negative bacterium V. parahaemolyticus. This conclusion was
supported by the results that (i) deletion of PvrK or its response regulator PvrR greatly
reduced the transcription of eptA and abolished the AMP resistance; (ii) deletion of eptA
abolished AMP resistance (iii) PvrK phosphorylation is promoted by addition of AMP to
LB media, or a low Mg2+ in the environment. Based on the results, a model was
proposed where membrane - associated histidine kinase PvrK sense the low Mg2+
concentration or the presence of AMP in the environment, leading to the PvrK
phosphorylation, phosphoryl transfer to PvrR, and, ultimately, the expression of PEA
transferase and less negatively charged LPS (Fig.3-10).
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AMP is the antibiotic that specifically target Gram negative bacteria as it binds to and
destructs LPS, a structure that is unique to gram negative bacteria. Except for efflux
pumps and formation of capsule, one of the most widespread resistance mechanism is
the covalent modification of LPS. The modifications include addition of fatty acid, 4amino-4-deoxy-L-arabinose (Ara4N) or phosphoethanolamine addition to the core and
lipid A, and acetylation of the O-antigen (122). One of the famous examples is that in S.
typhimurium, the TCSs of PmrA-PmrB and PhoP-PhoQ regulates AMP resistance by
regulating multiple lipid A modification genes, including genes involved in addition of
ethanolamine and aminoarabinose to the 4′ phosphate of lipid A (123). Moreover, it was
also reported that PhoPQ mediated regulation can produce a more robust outer
membrane with lower permeability, leading to increased resistance to multiple drugs
(124). Bader et.al fused a PhoPQ – regulated gene to PhoN reporter gene and showed
that AMP can activate reporter gene expression at intermediate Mg2+ concentrations;
moreover, they showed that the presence of AMP increased the kinase activity of PhoQ,
and speculated AMP can bind to periplasmic region of the PhoQ by Fe2+ mediated
cleavage assay and fluorescence assay (125). However, the gene regulated by PhoPQ
in their study was not shown to be responsible for any phenotype of S. typhimurium,
including the AMP resistance or Mg2+ concentration sensation. In contrast, our study
directly built up the causality between Mg2+ concentration/ AMP presentation to PvrK
phosphorylation and eptA expression. Furthermore, this mechanismof AMP resistance
is the first to be discovered in the Genus of Vibrio, this genus includes notorious
pathogens like Vibrio cholera and Vibrio parahaemolyticus.

90

Another interesting finding of this study relies in the fact that although PvrR genetically
forms a cognate TCS with PvrK, where the knockout mutant of pvrK or pvrR lost AMP
resistance, PvrR can still be phosphorylated without a functional PvrK. There are
basically two explanations for this scenario. The first possibility is that there existence of
cross talks between two different TCSs which is not uncommon in many cases (83).
When the cognate HK is un-functional, the RR can be phosphorylated by an alternative,
non-cognitive HK. A second possibility is that RR can be phosphorylated by alternative
phosphor-donors, such as acetyl phosphate. On the other hand, since complementation
of PvrR does not compensate ΔpvrK while the knockout of pvrR abolished AMP
resistance, it can be concluded that pvrR is essential but not sufficient for AMP
resistance, there must exist another regulatory protein that can be activated by PvrK
that is also responsible for AMP resistance.

In this study, we found that either low concentrations of Mg2+ or the presence of sublethal concentration of AMP resulted in LPS modification and thus AMP resistance of V.
parahaemolyticus. As V. parahaemolyticus is naturally found in the sea water, the high
salinity, especially the high concentration of Mg2+ (50mM) (126) of sea water, stabilize
the LPS of the outer membrane, so that LPS does not have to be modified or masked
with neutral or cationic groups; in this regard, PvrK remains inactivate and transcription
of eptA remains at minimal level. When the pathogen invades into human or other
animals, where the concentration of Mg2+ is around 1.08mM (127), the low Mg2+
concentration activate the PvrK and transcription of eptA. Moreover, as certain
members of AMP such as LL-37 is naturally present in human, and is part of the innate
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immunity, the presence of AMP further activate PvrK phosphorylation and the
development of AMP resistance in V. parahaemolyticus. Thus, the TCS of PvrK-PvrR
system can be also viewed as an important virulence factor that aids the survival,
persistence and invasion of V. parahaemolyticus upon infection.

Tables

Table 3.1 Strains and plasmids
Strains

Relevant

Source

genotype/description
Vibrio parahaemolyticus

Clinical isolate

(10)

RIMD 2210633

This work

RIMD 2210633
ΔpvrK

Δvpa1277
ΔpvrR

RIMD 2210633

This work

Δvpa1276
ΔeptA

RIMD 2210633
Δvpa1280

92

This work

ΔdgkA-eptA

RIMD

This work

2210633Δvpa1279-1280
ΔpvrK:ppvrK

ΔpvrK complemented

This work

with pvrK gene located in
pMMB207
ΔpvrR:ppvrR

ΔpvrR complemented

This work

with pvrR gene located in
pMMB207
ΔeptA:peptA

ΔeptA complemented

This work

with eptA gene located in
pMMB207
ΔpvrK:peptA

ΔpvrK containing eptA

This work

gene located in
pMMB207
ΔpvrK:pdgkA

ΔpvrK containing dgkA

This work

gene located in
pMMB207
ΔpvrK:pdgkA-eptA

ΔpvrK containing dgkA-

This work

eptA gene located in
pMMB207
ΔpvrK:ppvrR

ΔpvrK containing pvrR
gene located in
pMMB207

93

This work

ΔpvrK:ppvrKH221A

ΔpvrK complemented

This work

with mutated pvrK
gene(H221A) located in
pMMB207
ΔpvrR:ppvrRD58A

ΔpvrR complemented

This work

with mutated pvrR
gene(D58A) located in
pMMB207
Escherichia coli

KmR, thi-1, thr, leu, tonA,

SM10λpir

lacY, supE, recA::RP4-2-

This work

Tc::Mu, λpir
Escherichia coliDH5αλpir

supE44,

This work

ΔlacU169(ΦlacZΔM15),
recA1, endA1, hsdR17,
thi-1, gyrA96, relA1, λpir

Plasmids
pDM4-1276

Plasmid for deletion of

This work

vpa1276
pDM4-1277

Plasmid for deletion of

This work

vpa1277
pDM4-1280

Plasmid for deletion of
vpa1280

94

This work

pMMB207-1276

RBS and vpa1276

This work

sequences cloned into
pMMB207
pMMB207-1277

RBS and vpa1277

This work

sequence cloned into
pMMB207
pMMB207-1280

RBS and vpa1280

This work

sequences cloned into
pMMB207
pMMB207-1276His

RBS and vpa1276

This work

sequences with 6His
amino acid sequences
cloned into pMMB207
pMMB207-1277His

Vpa1277 sequences and

This work

6His amino acid
sequences cloned into
pMMB207
pMMB207-1277-H221A

vpa01277 sequences
with a point mutation in
histidine 221 and
sequences for 6His
amino acid cloned into
pMMB207

95

This work

pMMB207-1276-D58A

Vpa1276 sequences with

This work

a point mutation in
aspartic acid 58 and
sequences for 6His
amino acid cloned into
pMMB207
pGEX-1277SD

Sequences of vpa1277

This work

sensor domain cloned
into pGEX
pMMB-1277-T82A

Sequences of vpa1277

This work

with a point mutation in
threonine 82 cloned into
pMMB207
pMMB-1277-L85A

Sequences of vpa1277

This work

with a point mutation in
leucine 85 cloned into
pMMB207
pMMB-1277-K90A

Sequences of vpa1277

This work

with a point mutation in
lysine 90 cloned into
pMMB207
pMMB-1277-E91A

Sequences of vpa1277
with a point mutation in
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This work

glutamic acid 91 cloned
into pMMB207
pMMB-1277-V92A

Sequences of vpa1277

This work

with a point mutation in
valine 92 cloned into
pMMB207
pMMB-1277-F93A

Sequences of vpa1277

This work

with a point mutation in
phenylalanine 93 cloned
into pMMB207
pMMB-1277-F113A

Sequences of vpa1277

This work

with a point mutation in
phenylalanine 113 cloned
into pMMB207

Table 3.2 Primers used in this study
PRIMER NAME

SEQUENCE (5’-3’)

VPA1277_1F

GCTTATCGATACCGTCGACCCTCGAAGATTTGATGCTGCCG
GGC

97

VPA1277_1R

CGACTTGAACTGCGATGCCTGTTATGCGTTCCATGCATCCG

VPA1277_2F

CAGGCATCGCAGTTCAAGTCGCGGGCGAACAACGATAAAAG

VPA1277_2R

CACTAGTGACGCGTACTCGACGAGAGCTTGTGTTTTGGTG

VPA1276_1F

GCTTATCGATACCGTCGACCCTCGAAAGACGTTCCCTGACC
ACG

VPA1276_1R

CGACTTGAACTGCGATGCCTGGTAAGTGATGTGTGCTGTAT
TT

VPA1276_2F

CAGGCATCGCAGTTCAAGTCGGGAACGCATAAATGAGAAGG
ATATA

VPA1276_2R

CACTAGTGACGCGTACTCGAGTTCACGAATTCTGCGGCTTA

VPA1280_1F

GCTTATCGATACCGTCGACCCTCGAGCTTGCACCCATATTC
ACAAATG

VPA1280_1R

CGACTTGAACTGCGATGCCTGGGAGAATCAACAGTCTTCAT
AAGT

VPA1280_2F

CAGGCATCGCAGTTCAAGTCGCTGTCGAACCGTATCCTAAG
T

VPA1280_2R

CACTAGTGACGCGTACTCGAGTTGATTGGCGATAGCTGCAA
T

VPA1279-

GCTTATCGATACCGTCGACCCTCGACACAGAGATAATGGAT

1280_2F

TCACCC

VPA1279-

CGACTTGAACTGCGATGCCTGTACCTGGCTTCAAAATTGGG

1280_1R

C
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VPA1279-

CAGGCATCGCAGTTCAAGTCGCCTAAGTAGTTAGAGAAAGC

1280_2F

CTG

VPA1279-

CACTAGTGACGCGTACTCGAGCAAATAGTCGTTGTAGAGCG

1280_2R
VPA1276_PMMB

GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATAATG

_RBS_F

AACGAACAAGAAATCAAGCCATCC

VPA1276_PMMB

TCTCATCCGCCAAAACAGCCAAGCTTTAATGGTGGTGGTGA

_HIS_R

TGATGTGCGTTCCATGCATCCGG

VPA1277_PMMB

GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATAATG

_RBS_F

AGAAGGATATATCTAGAGAGC

VPA1277_PMMB

TCTCATCCGCCAAAACAGCCAAGCTTTAATGGTGGTGGTGA

_HIS_R

TGATGTTTAGGCAGAGATACGGTGAA

VPA1279_PMMB

GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATATTG

_RBS_F

AAGCCAGGTAAAACAGGAAT

VPA1279_PMMB

TCCGCCAAAACAGCCAAGCTCTAATGGTGGTGGTGATGATG

_HIS_R

AAGCAAGAACGACGCCC

VPA1280_PMMB

GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATAATG

_RBS_F

AAGACTGTTGATTCTCCAAAGA

VPA1280_PMMB

TCCGCCAAAACAGCCAAGCTTTAATGGTGGTGGTGATGATG

_HIS_R

GGATACGGTTCGACAGGT

1277_T82A_1R

AGCAGTGTGAGGTTGCAACAAT

1277_T82A_2F

ATTGTTGCAACCTCACACTGCTGATGAGCTCCCAC

1277_L85A_1R

AGCCTCATCCGTAGTGTGAG
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1277_L85A_2F

CTCACACTACGGATGAGGCTCCACCCGAGGTGAA

1277_K90A_1R

AGCCACCTCGGGTGGGA

1277_K90A_2F

TCCCACCCGAGGTGGCTGAAGTGTTCGATGA

1277_E91A_1R

AGCCTTCACCTCGGGTGG

1277_E91A_2F

CCACCCGAGGTGAAGGCTGTGTTCGATGAAG

1277_V92A_1R

AGCTTCCTTCACCTCGGGT

1277_V92A_2F

ACCCGAGGTGAAGGAAGCTTTCGATGAAGATCCTA

1277_F93A_1R

AGCCACTTCCTTCACCTCG

1277_F93A_2F

CGAGGTGAAGGAAGTGGCTGATGAAGATCCTAC

1277_F113A_1R

AGCGCGAAACCAAAAATCCC

1277_F113A_2F

GGGATTTTTGGTTTCGCGCTGACGAGAGCACTC

1277_T82A_CF

ATTGTTGCAACCTCACACTGCT

1277_L85A_CF

CTCACACTACGGATGAGGCT

1277_K90A_CF

TCCCACCCGAGGTGGCT

1277_E91A_CF

CCACCCGAGGTGAAGGCT

1277_V92A_CF

ACCCGAGGTGAAGGAAGCT

1277_F93A_CF

CGAGGTGAAGGAAGTGGCT

1277_F113A_CF

GGGATTTTTGGTTTCGCGCT

VPA0242RT_F

GCCATGATGACGGCGACAT

VPA0242RT_R

CACCTGCTGCGGCTTCTC

VPA1280_RT_F

ATGCACAGCAATCTTCGACC

VPA1280_RT_R

TACGGTCAAATTGATTGCGCGTT

VPA1279_RT_F

AAGCCGCGTGGACTCATG
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VPA1279_RT_R

TTTGGCTCGACCACTGAGTT

VP2509_RT_F

CAACATCGAGGCCGAACTC

VP2509_RT_R

CTGCTCACTGTGACACCTGA

VPA0243RT_F

CTTTGTACGCGTACACACCG

VPA0243RT_R

GTCTTCAGCGCTGTGCAGCA

1277_SENDOMIN AACGGATCCTATGAGCTCAATACTGATTATGACTA
_BAMHI_F
1277_SENDOMIN AACGAATTCTTAGTCGTCGAAATTGACGGCTT
_ECORI_R
1277H221A_PDM

GCTTATCGATACCGTCGACCCTCGAATGAGAAGGATATATCT

4_F

AGAGAGC

1277H221A_PDM

CACTAGTGACGCGTACTCGATTATTTAGGCAGAGATACGGT

4_R

GAA

1277H221A_CPM

TCACCAATGCGGTTGCTGCT

_F
1277H221A_CPM

GCATGGCATTGCGAAGTAGG

_R
1276D58A_PDM4

GCTTATCGATACCGTCGACCCTCGAGCAGTAGAGACGGAAC

_F

TGCT

1276D58A_PDM4

CACTAGTGACGCGTACTCGATTATGCGTTCCATGCATCCGG

_R
1276D58A_CPM_

CAACCCGATTTGGTTTTGTTAGC

F
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1276D58A_CPM_

CTGTTGGTTCATAGTGCAGGA

R
1277H221A_PMM AGCAGCAACCGCATTGGTGA
B_R1
1277H221A_PMM TCACCAATGCGGTTGCTGCTGAGCTACGCACACCAATTTTTC
B_F2
1276H58A_PMM

AGCTAACAAAACCAAATCGG

B_1R
1276H58A_PMM

CCGATTTGGTTTTGTTAGCTTTGATGCTGCCGGGCCAAG

B_2F
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Figures
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Figure 3-1. Identification of a histidine kinase that is essential for the resistance
of V. parahaemolyticus to antimicrobial peptide antibiotics and vancomycin. (A)
Mutants with deletion of predicted histidine kinases were streaked on LB agar
plate containing 15 μg/mL polymyxinB. (C) Vpa1277 was designated as PvrK.
Deletion of pvrK (vpa1277) or pvrR (vpa1276) abolished the ability of V.
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parahaemolyticus to resist polymyxin E (colistin). Point mutation of H221A to
PvrK or D58A to PvrR also abolished the ability of V. parahaemolyticus to resist
polymyxin E. Complementation of ΔpvrK with WT pvrK or ΔpvrR with WT pvrR
restored polymyxin E resistance. (D) Deletion of vpa1277 abolished the ability of
V. parahaemolytic to resist LL-37. (E) Deletion of pvrK (vpa1277) or pvrR
(vpa1276) abolished the ability of V. parahaemolyticus to resist polymyxinB.
Point mutation of H221A to PvrK or D58A to PvrR also abolished the ability of V.
parahaemolyticus to resist polymyxinB. Complementation of ΔpvrK with WT pvrK
or ΔpvrR with WT pvrR restored polymyxinB resistance.
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Figure 3-2. PvrK is predicted to be a membrane protein with two potential
transmembrane regions located at amino acids 8–21 and amino acids 140–161,
respectively (http://tmdas.bioinfo.se/cgi-bin/tmdas.cgi).
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Figure 3-3. KEGG pathways negatively affected in DpvrK mutants.
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Figure 3-4. RT-PCR confirmation of transcription of pvrK regulon. Indicated
strains were cultured in LB. House keeping gene gyrB as an internal control.
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Figure 3-5. In vivo phosphorylation analysis of PvrK or PvrKH221A in the indicated
strains, and phosphorylation analysis of PvrR or PvrRD58A in the indicated strains.
All strains are grown in LB.
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Figure 3-6. PvrR does not form cognate RR with PvrK functionally. (A)
Complementation of WT PvrR into ΔpvrR or pvrRD58A barely restored the ΔpvrR
resistance to polymyxinB. All strains are grown on LB agar plates with 15ug/ml
polymyxinB. (B) Phos-tag SDS-PAGE of PvrR. PvrR can be phosphorylated
when PvrK is absent or mutated
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Figure 3-7. AMP resistance of dagK and eptA. (A) Deletion of either dagK or eptA
abolished AMP resistance; Complementation of both dagK and eptA to pvrK
mutant fully restored polymyxinB resistance to WT level. (B) Deletion of both
vpa1279-1280 genes abolished AMP resistance while complementation of
Δvpa1279-1280 with WT Vpa1279-1280 restored the resistance.
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Figre 3-8. High Mg2+ inhibits PvrK phosphorylation. (A) In vivo phosphorylation
analysis of PvrK or PvrKH221A in LB or LB supplemented with 2mM and 10mM
Mg2+. (B) RT-PCR analysis of eptA(vpa1280) and vpa0243 expression in pvrK or
pvrKH221A complementation strain when growing in LB or LB with 10mM Mg2+,
with gyrB as an internal control.
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Figure 3-9. The role of AMP in the phosphorylation of PvrK when V.
parahaemolyticus was cultured in LB with high concentration of Mg2+. (A) In vivo
phosphorylation analysis of PvrK in LB, LB with 10mM Mg2+ and LB with 10mM
Mg2+ and 10ug/ml polymyxin B. (B) RT-PCR analysis of eptA(vpa1280) and
vpa0243 expression in pvrK or pvrKH221A complementation strain when growing in
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Lb, LB with 10mM Mg2+ or LB with 10mM Mg2+ and 10ug/ml polymyxin B, with
gyrB as an internal control.

Figure 3-10. Schematic model for PvrK/PvrR-mediated eptA expression.
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